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Abstract 
 
The Formylglycine generating enzyme (FGE) catalyses the oxygen dependent oxidation of a highly 
conserved cysteine residue in sulfatases and phosphatases to formylglycine (fGly).[3] In sulfatases 
the hydrated form of fGly serves as the catalytic residue to cleave sulfate esters of their 
substrates.[46][47] After the first identification of FGE as the key enzyme in sulfatase activation, it 
has been quickly associated with multiple sulfatase deficiency (MSD), a rare but fatal lysosomal 
storage disease. Various mutations in the FGE encoding SUMF1 gene have been identified in 
patients suffering from MSD.[48]   
Alongside the medicinal importance, FGE has gained significant attention due to the fact, that it 
has been identified as a cofactor-independent oxidase with an unkown mechanism of oxygen 
activation. The absence of metals and cofactors in published crystal structures and enzyme 
preperations raised the question of how oxygen activation can occur.   
We hereby show that FGE is a copper dependent oxidase. Recombinant FGE from 
Thermomonospora curvata contains a disulfide bond but is readily reduced in the presence of 
reducing agents such as DTT or cysteamine. Reduced FGE shows a near atto molar affinity to 
copper(I) and binds copper throughout multiple turnovers. Copper binds to two highly conserved 
cysteine residues in the active site of FGE where it is involved in oxygen activation. While copper 
can be replaced by other metals such as silver, only copper facilitates the reaction, which 
supports its participation in redox chemistry.   
Furthermore, we describe the dependence of FGE on a peptidyl reducing agent containing a 
thioredoxin-like CxC amino acid motif. FGE from Homo sapiens is linked to an N-terminal domain 
bearing the CxC sequence. This peptide tag is believed to be involved in retention of FGE to the 
ER. We additionally suggest that this domain serves as the immediate reducing agent of FGE and 
is then reduced by other pathways. Sequence similarities of this domain to the substrate 
polypeptide indicate that the N-terminal domain binds to the substrate binding groove of FGE. 
This suggests a ping-pong mechanism of product formation and subsequent reduction of the 
oxidized enzyme intermediate.   
In addition to the mechanistic interest, FGE has been used as a tool to site-specifically introduce 
aldehyde functionalities into recombinant proteins for further bioconjugation. We now identify a 
set of five mutations which increases the catalytic efficiency of FGE by 38-fold. The resulting 
variant completely oxidizes a specific cysteine residue in a target protein within 90 min with only 
0.3 % of catalyst loading at room temperature. This high reactivity is maintained even when the 
recognition motif is installed into an internal loop region of the target protein.  
We envision that these findings will not only drive the mechanistic discussion about the 
previously mysterious oxygen activation in FGE but will also support the usage of fGly in 
bioconjugation research. 
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1. Understanding the impossible 
nzymes belong to the most fascinating creations of nature. To fully understand how these 
protein catalysts can perform the most difficult reactions with exceptional specificity or simply 
how they form stable constructs is still one of the main quests of scientists all around the globe. 
The first enzyme to be discovered appeared to be a diastase in the 1830s.[1] Not until the early 
19th century, however, the very first enzyme was purified and crystallized. This groundbreaking 
work was then little later acknowledged with the Nobel Prize in Chemistry for Sumner, Northrop 
and Stanley in 1946.[2] Curiosity and the eager for knowledge have thriven many scientists and 
researchers to investigate the complex mechanisms behind enzymes ever since.  
The formylglycine generating enzyme (FGE) is such an enzyme that captivates the scientific 
community in recent years. It catalyzes the site specific oxidation of a conserved cysteine residue 
within sulfatases.[3] Disfunction of sulfatases causes a rare but lethal desease, the multiple 
sulfatase deficiency (MSD).[4] In pursuit of investigating possible treatments of MSD, 
understanding the details of FGE catalysis is key. In addition to the medicinal interest, FGE has 
gained considerable attention due to widespread applications opening up in the field of covalent 
protein labeling and immobilization.[5][6]  
However, research in FGE has been driven mainly due to another key characteristic: the absence 
of metals and cofactors while performing an oxidase type reaction. Oxygen dependent oxidation 
of organic matter is subject to the rules of quantum chemistry, meaning that molecular oxygen in 
its triplet state, as present in the atmosphere, cannot react with unactivated organic matter (see 
chapter 2). Dioxygen is a diradical in the triplet state and does not sponaneously react with other 
molecules in the singlet state. However, enzymes exist which perform oxygen activation and do 
not rely on convential activation mechanisms such as metal ions or organic cofactors. To some 
extent this observation might appear impossible. Careful evaluation, however, shows that these 
enzymes often perform reactions by using ‘cofactor-like’ substrates.[8][9]   
The substrate of FGE is a simple polypeptide consisting of only proteogenic amino acids. The 
mechanisms of oxygen activation by FGE in absence of cofactor or metal can not be understood. 
It has therefore been a main target to elucidate the questionable mechanism and to understand 
the FGE-catalyzed oxygen activation.  
This work describes the investigation of the FGE mechanism and the resulting identification of 
FGE as being a copper(I) dependent oxidase. 
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2. Introduction - Oxygen and Metals in Enzyme Mechanisms 
bout 2.45 billion years ago the earth was a different place to the world we live in today. 
Geological and geochemical evidence shows, that the level of atmospheric oxygen was 
significantly lower than it is today.[11] The amount of available oxygen increased to considerable 
levels by 2.2 billion years ago when the first organisms, such as cyanobacteria, released 
molecular oxygen into the atmosphere.[12] Higher organisms evolved, by using the increased 
oxygen levels to produce energy for their living. Most ‘recently’ the Homo sapiens populated the 
now oxygen rich world, only thanks to the first appearance of O2 billions of years in the past. 
Even though anaerobic organisms exists, to which oxygen in fact is toxic[13], the vast majority of 
today’s animal kingdom uses oxygen for their living.[14]  
Long before oxygen found its way into the biochemistry of low level organisms, transition metals 
were present to play central roles in catalysis. The oceans of the ancient world were filled with 
water soluble metal salts that could be readily incorporated into the simple single cellular 
organisms of that time.  
When the concentration of molecular oxygen in the atmosphere increased, new enzymatic metal 
centers evolved that could make use of both, redox properties of the transition metals and the 
oxidation potential of molecular oxygen. A new world of chemistry has been opened up for many 
new organisms to develop unique biochemical and biosynthetical pathways and to create the 
world in which we happen to live to date. 
2.1 Oxygen Using Enzymes - From Oxydases and Oxygenases 
When oxygen became available for an increasing number of organisms, new chemical pathways 
were developed. However, all of them had to face one key property of molecular oxygen - 
unreactivity towards singlet molecules.[7] Oxygen is a molecule in a triplet state (two unpaired 
electrons). Organic matter is mostly present in a singlet state (only paired electrons). Organisms, 
more particularly enzymes within the organisms, where therefore faced with one major problem: 
Oxygen activation. For a reaction to occur, oxygen in the triplet state has to be excited or 
activated to the singlet state in order to overcome the spin restriction (see Fig. 2-1 and Eq. 1). 
While the formation of the peroxyl radical is endothermic, hence requires an energy input (E0’ for 
O2/O2
∙- = -0.33 V), the following hydrogen peroxyde formation can occur spontaneously.   
Many enzymes have evolved which can overcome the initial energy barrier and in the following 
reaction can harness the oxidizing capability of molecular oxygen. In order to make use of the 
strongest available oxidant in biology, enzymes such as oxygenases often contain redox-active 
metal ions that are capable of transfering a single electron to dioxygen (i.e. iron(II), copper (I)). 
Others use organic cofactors to act as an electron donor (i.e. flavins).[15] However, some rather 
rare examples exist in which enzymes are able to activate oxygen without the requirement of 
external reagents.[16] In general, enzymes that use dioxygen can be devided into two groups, 
oxidases, which use oxygen as an electron acceptor and reduce it to water or hydrogen peroxide, 
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Fig. 2-1: Molecular orbital diagrams for triplet (3O2) and singlet oxygen (
1O2). 
 
and oxygenases, which incorporate the oxygen atoms into the substrate and product molecules. 
This group again devides in two sub-groups. Mono-oxygenases only incorporate a single oxygen 
atom whereas di-oxygenases transfer both atoms of dioxygen to the substrate. Most 
dioxygenases use metal ions in there active centres. These transition metal containing enzymes 
can use mainly three strategies to activate oxygen.[15] Firstly, orbitals with unpaired 3d electrons 
of the transition metal can overlap with the π* orbitals of the oxygen molecule, containing the 
unpaired electrons (see Fig. 2-1). The resulting complex of metal and oxygen can then undergo 
reactions with singlet molecules. Secondly, single electron transfer from the metal to oxygen can 
occur. Transition metals in enzymes can often be found in two distinct oxidation states (i.e. 
Cu(I)/Cu(II) or Fe(II)/Fe(III)). These metals can transfer a single electron to dioxygen, which 
generates superoxide (see Scheme 2-1, A). The following reaction of superoxide (a singlet 
molecule) and organic matter in the singlet state is then allowed. The oxidized metal ions 
consequently need to be reduced by a suitable reducing agent to be able to perform the next 
electron transfer reaction.  
A third method of oxygen activation is single electrons transfer from organic molecules that can 
stabilize radicals. These cofactors, such as flavins or NADH, can similarly directly react with 
dioxygen (see Scheme 2-1, B). A hydrogen atom is transferred from flavin to triplet oxygen, 
generating two radical molecules. Upon spin inversion the reaction partners collapse into flavin 
hydroperoxide.[17] A last possible pathway to allow for reaction with oxygen is activation of the 
substrate. While the reaction of triplet oxygen with organic material, that contains only paired 
electrons, is quantum chemically forbidden, the reaction with radicals is a spin-allowed process. 
Such reactions occur when substrate molecules can stabilize radicals, such as in the case of 
intradiol catechol dioxygenase (see Scheme 2-1 C).[18] The required substrate activation has been 
studied using artificial catechol iron complexes. It is believed that the Lewis acidity of the iron 
atom increases the covalent character of the iron-catechol interactions, which in turn enhances 
the semiquinone character of the bound ligand and makes the catechol ligand more prone to 
oxygen attack.  
While there are many examples in which oxygen activation can be performed under participation 
of metal ions (even earth abundant transition metals such as molybdenum, as in the case of 
xanthine oxidoreductase[19]) or organic cofactors, only few enzymes catalyze cofactor and metal-
free oxygen activation. 
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Scheme 2-1: Enzymatic approaches to oxygen activation. A: Electron transfer from a metal to triplet oxygen to 
generate superoxide, which can undergo reactions with organic material. B: Hydrogen atom transfer from flavin to 
molecular oxygen, followed by recombination of superoxide with the resulting flavin radical. C: Metal assisted radical 
formation on the substrate, with subsequent recombination of substrate radical and 3O2.  
  
 
2.1.1 Cofactor-Independent Oxidases 
One particular and well studied example of cofactor-free oxidases is the urate oxidase (UOX). The 
enzyme belongs to the purine degredation cascade and more specifically catalyzes the 
hydroxylation of uric acid (see Scheme 2-2). By the use of EPR spectroscopy, a number of radicals 
are readily observable upon simple mixing of UOX and uric acid.[21] These different radical species 
were assigned to be of the same origin, since the structure of uric acid allows for easy 
delocalization of the unpaired electron throughout the molecule. Different radical traps then are 
capable of traping different products depending on the delocalization of the radical. How UOX 
does activate oxygen or the substrate remains unclear. Typically, oxidases that do not use 
cofactors or metals activate oxygen first, which then reacts as superoxide radical anion (∙O2
-) 
leading to peroxidation of the substrate. However, no superoxide or hydroxyl radicals were 
observed in case of UOX, indicating that these either do not form or do not leave the active 
site.[21]  
 
Scheme 2-2: Reaction catalyzed by UOX under participation of molecular oxygen and the follow-up reaction to yield 
allantoin, the final degredation product. 
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2.1.2 Cofactor-Independent Oxygenases 
Similarly to cofactor-free oxidases, oxygenases exist that do not require an external electron 
donor for the reaction to be catalyzed. In biotechnology the green fluorescent protein (GFP) from 
marine organisms such as Renilla reniformis (a sea pansy), has grown to a laboratory standard 
within the last decades. This was mainly due to its ease to be produced and the characteristic 
fluorescent emission upon irradiation with light. Luciferase (RLuc) is an enzyme also found in R. 
reniformis. When the sea pansy is disturbed, a cascade of nervous system responses triggers the 
release of Ca+ ions which in turn causes the release of coelenterazine (the substrate of RLuc) from 
the coelentrazine binding protein. RLuc then catalyzes the monooxygenation of the substrate and 
releases the product as well as carbon dioxide while emitting blue light in the process. In the 
organism, resonance energy transfer occurs, transmitting the energy to GFP which then emits its 
characteristic green light (λem,GFP = 509 nm). The luciferase reaction is believed to proceed via an 
attack of dioxygen to C2 of the substrates imidazole ring (see Scheme 2-3). Intramolecular attack 
could then lead to the release of carbon dioxide and light. Imidazolopyrazinones undergo easy 
dioxygenolysis in aprotic solvents, when a suitable base is also present, making luminescence 
visible even in the absence of a catalyst.[20] Hence, the luciferase ‘simply’ has to do little more 
than providing a suitable binding site as well as a catalytic base.  
 
Scheme 2-3: Proposed reaction pathway of luciferase from R. reniformis.[8] 
The examples of cofactor-free oxydases and oxygenases shown above share one common 
feature: the basic structure of the substrate is aromatic and rich in carbonyls. With regards to 
other cofactor-free oxidases and oxygenases (see Scheme 2-4) this trend continues on. Without 
any doubt, analogies to cofactors such as flavin adenine dinuclotide (FAD, see also Scheme 2-1) 
exist. One can interpret these substrates as cofactor-like molecules, which perform similar tasks 
and can consequently act as electron donor itself. The requirement for external cofactors is 
thereby omitted.  
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Scheme 2-4: Substrate scope of cofactor-independent oxidases (A) and oxygenases (B) for which substrate assisted 
oxygen activation has been observed.[21]-[25] 
 
2.2 Metals in Enzyme Active Sites 
The cellular machinery is tightly connected to the presence of metal cations catalyzing a variety 
of reactions within numerous metalloenzymes. Examples range from ‘simple’ tasks such as 
protein structure stabilisation, signalling, Lewis acid functionalities but also more complex 
reactions such as electron transfer and oxygen activation. These metal-cofactors are very simple 
but at the same time highly versatile cofactors. Based on their specific chemical and physiological 
function, a large variety of metals have found there way into the cells of living organisms.[26][27] 
2.2.1  Iron enzymes 
Among the many metal cations found in nature iron plays a prominent role. Heme coordinated 
iron is the central cation in the oxygen transport system of eukaryotic organisms. It therefore 
most likely presents the best known metal in the human body even in the non-scientific 
community. While there are noumerous enzymes using heme-coordinated iron (i.e. P450 
monooxygenases) an array of protein catalysts can tightly bind single iron atoms in their acitve 
centres. These enzymes similarly perform a wide range of reactions involving molecular oxygen. 
Non-heme iron binding sites typically contain histidine and carboxylate residues but also 
tyrosines and other hydroxy groups are often involved.[14] One example of such iron binding 
enzymes is the sulfoxide synthase EgtB, which is an essential enzyme in the biosynthesis of 
ergothionine, a 2-thio-histidine.[28] As with many metal enzymes, oxygen activation is achieved by 
electron transfer from the iron center towards O2. Oxygen is then reduced by electron transfer 
from γ-glutamyl cysteine, yielding a thiyl radical and an iron coordinated peroxide derivative (see 
Scheme 2-5, A). The sulfur radical then further proceeds to the product by C-S bond formation 
with trimethyl histidine. Quite interestingly, upon mutation of a single active site residue  
 
 8 
 
 
Scheme 2-5: Proposed mechanism of EgtB from Mycobacterium thermoresistibile. Oxygen activation occurs upon 
binding to the iron center were one electron is transferred to generate the peroxyl radical anion. 
(Tyr377Phe) this reactivity can be altered to generate a cysteine dioxygenase activity (see 
Scheme 2-5, B). Removal of the hydrogen bonding tyrosine residue changes the protonation state 
of the iron bound oxygen. This then weakens the oxygen-oxygen bond, which in turn yields a 
favourable O-O bond cleavage. One oxygen atom is then transfered to the sulfur atom of γ-
glutamyl cysteine to generate the oxidized product.   
This example shows the whide array of oxidation reactions that can be catalyzed by iron center 
enzymes even if only small changes are introduced into the active site. 
2.2.2  Copper oxidases and oxygenases 
Aside from iron, another very prominent metal in enzyme active sites is copper. Copper plays an 
important role in living systems. Although being present in only the parts per million 
concentration range in the living cell, it is a key element in a variety of biological oxidation and 
reduction reactions.[30][31]  
Copper in biological systems can most often be found in two distinct redox states. The vast 
majority of proteins display a copper(II) active site. Noteworthy and well studied examples for 
this class of copper enzymes are galactose oxidase and copper amine oxidases.[32][33] Galactose 
oxidase has been known since the late 1950s and hence is one of the best known copper 
containing enzymes. Nethertheless it bears quite an interesting active site (see Fig. 2-2 left). The 
copper(II) ion is coordinated in a square pyramidal geometry by a number of histidine and 
tyrosine residues. More interestingly, one of the tyrosine residues has undergone post 
translational modification to afford a cofactor which contains a C-S bond linked structure of a 
tyrosine and a cysteine residue. It is believed, that the ortho configuration of the carbon-sulfur 
bond favours the delocalization of the π-system towards the sulfur, which can stabilize a radical 
on the tyrosine hydroxyl group. A tryptophane residue right in place on top of the cysteine-
tyrosine cofactor further stabilizes the delocalized system.[34] This unique architecture then 
reduces the redox potential of said tyrosine residue from ≈ 0.9 V to ≈ 0.4 V. 
Copper-dependent amine oxidases (CAOs) represent a different example of copper dependent 
enzymes that additionally contains an enzyme originated cofactor. CAOs catalyze the oxidation of 
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a primary alcohol to an aldehyde functionality. They display an ubiquitous group of enzymes that 
can be found in various domains of life such as bacteria, yeast, plants and mammals.[35] The acitve 
site contains copper(II) which is held in place by coordination to three histidine residues and a 
number of water molecules. In addition to the copper ion the active site containes a tyrosine 
derived cofactor, namely 2,4,5-trihydroxy-phenylalanine (topaquinone, TPQ). Interestingely 
copper is only required for the cofactor genisis, but does not participate in the actual turnover, 
where copper coodinated water provides hydrogen bonding towards the deprotonated cofactor. 
The substrate amino group forms a Schiff base with C3 of TPQ which hydrolyses to form the 
aldehyde (similar to the transamination mechanism). The amino group resides on the cofactor 
and under participation of oxygen and water is again hydrolysed to the aldehyde containing 
recycled TPQ.   
The cofactor alone is believed to adopt a rather flexible orientation. When TPQ is coordinated to 
copper (adopting the “on-copper” conformation) the enzyme is in fact inactive. Upon binding of 
C4-oxygen to the copper ion the orientation is fixed, which causes the cofactor to face away from 
the substrate entry channel and hence inactivates the complex.[36] This being said, the 
multifarious traits of copper in enzymatic acitve sites are clearly shown. 
 
 
   
Fig. 2-2: Top: Reactions catalyzed by galactose oxidase (GO) and copper-dependent amine oxidases (CAO) Bottom: 
Active site view of galactose oxidase (left, PDB code 2EIC) with the tyrosine-cysteine cofactor and copper dependent 
amine oxidase (right, PDB code 1IU7) with TPQ.[37][38] 
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2.2.3  Copper(I) Enzymes 
Copper binding motifs in Cu2+-enzymes display related active site structures with mainly nitrogen 
and oxygen based ligands. Different protein structures, however, have evolved that specifically 
bind Cu+ ions. Although examples exist that bind copper(I) in a histidine rich active site (i.e. 
Hemocyanin, contains two copper(I) atoms that upon irreversible oxygen binding are oxidized to 
Cu2+ [39][40]), most copper(I) binding sites typically contain an increased number of cysteine 
residues and show high affinities to the metal cation. Further differences arise with regards to 
the function of these enzymes. Copper(II) containing proteins often catalyze redox reactions 
which involve electron transfer from copper to substrates and cofactors.[31] Quite differently, the 
function of many Cu(I) proteins is copper transport in which the redox state of the metal ion is 
not affected. A typical example of these chaperon-like proteins is the Cu(I)-binding protein 
Atx1.[41] Being involved in copper transport to a second copper-containing protein, the P-Type 
ATPase, it requires to tightly bind copper but also efficiently release the metal at a later stage. 
Copper is delivered across the membrane to the trans-Golgi network where it will be further 
distributed to other metal proteins.[42] The metal binding site of Atx1 is dominated by a 
conserved MxCxxC motif located on a solvent accessible and flexible loop (see Fig. 2-3). Similar to 
other copper chaperons like Ccs1 (a copper transporter for superoxide dismutases[43]) and Cox17 
(delivering copper ions to cytochrome c oxidase[44]) this cysteine rich motif ensures thight binding 
of copper(I) with a KD of ≈ 10
-17 M.  
 
Fig. 2-3: Active site view of human Atx1 (PDB code 1FEE) with Cys12 and Cys15 being involved in copper binding. 
 
2.2.4  Lytic polysaccharide monooxygenases 
In the last years copper dependent lytic polysaccharide monooxygenases have gained reasonable 
interest due to their capability of breaking glycosidic bonds to produce biofuel from organic 
materials. They are found in many different organisms such as fungi and bacteria, but also 
viruses.[67] They do not share remarkable sequence homology, however, the overall fold as well 
as the structure of the active site appears to be similar.   
The central feature of LPMO catalysis, is the copper atom at the surface of the reactive pocket. It 
is coordinated by two histidine residues (one of which is additionally methylated at the δ-
nitrogen in fungal LPMOs) as well as water molecules.  These will be replaced by the hydroxy 
groups of the sugar upon substrate binding.[66]  
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Scheme 2-6: Overall reaction catalyzed by LPMOs (A) with two proposed mechanisms (B).[68] 
The mechanistic details of LPMOs have been subject to various research projects with different 
outcomes. In general, two distinct mechanisms are proposed (see Scheme 2-6) with different 
orders of action.[68] In both cases the catalytic cycle is initiated by oxygen activation via binding of 
molecular oxygen to the Cu(I) species in the resting state. The resulting superoxide radical anion 
species can then undergo direct reaction with the substrate (Scheme 2-6, B right pathway) to 
generate the substrate radical as well as the peroxide anion coordinated copper center. The 
latter is then reduced by a suitable reducing agent to generate a Cu(II)-oxyl radical which upon 
recombination with the radical substrate is transfered into the product.   
The second suggested mechanisms involves the formation of a rather unusual Cu(III) species 
(Scheme 2-6, B left pathway) which is generated by heterolytic O-O bond cleavage and release of 
water after the initial superoxide radical anion species is reduced to the cupric peroxy species. 
The resulting Cu(III) species has been hypothesized in analogy to Compound I in P450s[69] and can 
be stabilized by a close by tyrosine residue in the active site. Model complexes have been 
synthesized that resemble the nature of this intermediate.[70] Hydrogen atom abstraction from 
the substrate is followed by radical recombination to yield the product as well as the cupric 
enzyme which can be reduced to the cuprous species, upon which the catalytic cycle is then 
closed.  
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2.3 Formylglycine Generating Enzyme 
Nature has evolved a number of setups in order to tame the janus-faced temper of molecular 
oxygen. Examples are cofactor participation or redox active transition metals. However, other 
proteins exist, that do not require such assistance, but at the same time are capable of oxidizing 
their respective substrates in the absence of external support ((see chapter 2.1 and 2.2). These 
specialized enzymes however typically perform reactions on substrates with extended π-systems 
in polycyclic aromatic substrates. The oxidation of less electron rich substrates, though, still 
remains a challange.   
The Formylglycine generating enzyme (FGE) has been described as being capable of oxidizing a 
specific cysteine residue within a defined motif of sulfatases during translation (see Scheme 
2-7).[3][45]   
 
Scheme 2-7: Oxidation of a sulfatase cystein catalyzed by the formylglycine generating enzyme.  
 
2.3.1  Sulfatases in Homo sapiens 
Sulfatases catalyze the hydrolysis of sulfate groups on various different substrates. The family of 
sulfatases contain a number of subgroups with different function, however they share a common 
active site residue. The catalytic activity requires one of the active site cysteines (in some 
sulfatases this can be a serine ) to be oxidized to formylglycine (fGly) which hydrolyses to the diol 
form in the mature sulfatase (see Fig. 2-4, left).[46][47] A base mediated nucleophilic attack towards 
the sulfate group of the substrate yields the product as well as the sulfated diol. Deprotonation 
of this then results in the release of sulfate as well as the aldehyde containing enzyme. The highly 
conserved cysteine residue is located in an CxPxR motif (see Fig. 2-4, right) that triggers substrate 
 
 
Fig. 2-4: Left: Mechanism of aldehyde catalyzed sulfate ester cleavage by sulfatases. Right: Sequence logo showing the 
conservation of the active site motif CxPxR in 100 sulfatases homologues (after BLAST search) in H. sapiens. 
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recognition by FGE. The cleavage of sulfate esters is therefore dependent on the presence of the 
fGly residue in the active site. Insufficient sulfatase activity leads to a rare but severe disorder 
called multiple sulfatase deficiency (MSD).[48] Patients suffering from MSD show very low activity 
of all sulfatases which has been traced back to disfunction of FGE. It was shown that FGE not 
effieciently introduces the active site aldehyde in these patients. Gene sequencing revealed a 
number of mutations on the sulfatase modifying factor 1 gene (SUMF1) which expresses to the 
formylglycine generating enzyme.[49] These mutations result in deletions of sequences within FGE 
(loss of residue 327-366 upon deletion of G661 in SUMF1) or altered conserved residues 
throughout the enzyme scaffold, but mostly in the C-terminal subdomain of FGE (i.e. R349W/Q or 
C336R). While the individual gene defects were of different nature, seven out of seven patients 
showed mutations or deletions in subdomain three of FGE (Arg327-Ala366, C-terminal domain), 
suggesting the particular importance of this domain. 
2.3.2  FGE in human cells 
In humans, after expression of SUMF1 in the endoplasmic reticulum (ER), FGE remains localized 
in the ER where it ultimately performs catalysis on the respective sulfatases. FGE does not 
contain a signaling peptide sequence of the KDEL type, suggesting that interactions with other 
proteins cause FGE to remain in the ER.[49] It interacts with protein disulfide isomerase (PDI) and a 
ER resident protein (ERp44), both of which are members of the thioredoxin familiy as well as 
ERGIC-53, a lectin, moving between the golgi and the ER.[50] The interaction with ERp44 occurs 
through a N-terminal domain of FGE (residue 34-68 of the human variant) through disulfide bond 
formation as well as non-covalent interactions.[51] This N-terminal domain has been identified as 
being crutial for retention in the ER and hence for in vivo activity, but appears to be dispensible 
for in vitro reactivity. It contains two cysteine residues (Cys50 and Cys52) that are involved in 
binding to ERp44 but also lead to homodimer or intramolecular disulfide bond formation.[45] The 
homodimer, however, appears to be labile and is readily reduced to the monomers in the 
presence of reducing agent. The in vivo activity only depends on the presence of Cys52 but not 
Cys50.[51]  
The enzyme additionally contains a N-glycosylation at Asn141, which however is not essential for 
the function. [52] A part of FGE is secreted from the ER and upon cleavage of the N-terminal 
domain (residue 34-72) the majority is inactivated. However, 20-30 % are not truncated and 
remain active.[53] The glycosylation at Asn141, though, does not influence secretion.[52]   
Modification of the sulfatase substrate occurs inside the ER where FGE catalyzes the oxidation 
co-translationally with expression of the substrate gene.   
SH SH O
O
unfolded
Sulfatase
partially folded modified folded
 
Fig. 2-5: FGE catalysis on sulfatases occurs co-translationally in the endoplasmic reticulum. 
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2.3.3  Structure of FGE 
Crystal structures of FGE have been published for enzymes (Streptomyces coelicolor) from 
bacterial and eukaryotic (Homo sapiens) organisms. The structures from the different sources 
share the same fold with a rmsd of 0.65 Å and provide excellent tools for researchers 
investigating FGE.[54] The overall fold of the enzyme is quite unique and has hence been described 
as the FGE-fold with 64 % adopting a random coiled secondary structure (see Fig. 2-6, top). This 
fold has been identified as a subclass of the C-type lectin fold.[55] While human FGE contains two 
Calcium atoms, the bacterial homologue only binds one. Asparagine 141 in human FGE is N-
glycosylated with a N-acetyl glucosamine.  
Both, human and bacterial, FGE contain a number of conserved cysteine residues. The eukaryotic 
variant contains six cysteines that are oxidized to cystines, while the prokaryotic protein only 
contains five, with one disulfide bond between Cys272 and Cys277. Three out of these cysteines 
are highly conserved, with two of them being positioned in the active site of the enzyme (see Fig. 
2-6, bottom). Additional crystal structures of human FGE show these two residues under various 
oxidizing conditions. Sulfenic and sulfonic acids have been observed. A cysteine mutant of human 
FGE (Cys336Ser) has additionally been cocrystallized with a substrate peptide (sequence: 
LCTPSRA), showing a disulfide bond between the remaining Cys341 and the substrate cysteine. 
This furthermore led to the identification of the substrate binding groove on the surface of FGE. 
In addition to contacts to water molecule and the peptide backbone, other key interactions 
between the substrates conserved CxPSR motif and FGE are hydrogen bonding of the serine 
hydroxy group with Asn352 and of the arginine with Asp154, Asp355 and Ser357. With a total 
number of six van-der-Waals contacts, the terminal arginine residue appears to be of high 
importance (see also sequence conservation in sulfatases, chapter 2.3.1). 
 
  
 
 
Fig. 2-6: Top: X-ray structure of FGE from Homo sapiens (left, PDB 1Y1E [48]) and Streptomyces coelicolor (right, PDB 
2Q17[54]) colored according to secondary structure (helices: cyan; β-sheet: red; random coiled: magenta). Cysteine336 
and Cys341 are colored in blue. Calcium atoms are shown in yellow. Bottom: Sequence alignment of FGE from Homo 
sapiens, Streptomyces coelicolor, Thermomonospora curvata and Mycobacterium smegmatis, with conserved active 
site cysteines highlighted in green. 
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 The availability of FGE crystal structures has furthermore driven mechanistic investigations. The 
covalently linked substrate in the active site being one main feature of the proposals, it remains 
unclear how oxygen activation can occur in the absence of metals or cofactors.  
 
2.3.4  FGE mechanism 
The FGE catalyzed reaction is one of the most remarkable oxidation reactions known. The 
oxidation of the thiol group without participation of metals or cofactors is complex and a 
complete understanding of the underlying mechanisms still lacks. After the first identification of 
FGE it has been shown to be dependent on oxygen, most likely as terminal electron acceptor.[45] 
Additionally, the dependence on reducing agent has been demonstrated. Cell extracts containing 
FGE were assayed in the presence of GSH and DTT, upon which an elevated aldehyde formation 
was observed.[3] In search of answers regarding the basis for oxygen activation various crystal 
structure have been reported including bacterial (Streptomycese coelicolor) as well as human 
enzymes (see above page 14).[48][54] The human FGE contains six cysteine residues. Two of thees 
cysteines have been identified as being highly important for activity. In fact, upon co-
crystalization of FGE with a short peptide representing the substrate binding motif, a mixed 
disulfide between the substrate and the enzyme is observed.[56] Additionally, the importance of 
the two highly conserved cysteine residues Cys336 and Cys341 (numbering based on human 
variant) has been shown in serine mutants of the respective amino acid which show only residual 
activity in vivo. Several mechanismns have since been proposed, most of which include disulfide 
bond formation between the substrate and the enzyme (see Fig. 2-7) which is the first step of the 
proposal. This mixed disulfide is then subject to the formal addition of oxygen, being the most 
questionable step as oxygen activation is required for this reaction to occur. However, it follows 
that the sulfur-peroxyde intermediate is reduced by an apropriate reducing agent which leads to 
the formation of a first equivalent of water as well as the sulfenic acid on the enzymes cysteine. 
Subsequent disulfide bond shuffling releases the enzyme in it’s resting state as well as the 
substrate sulfenic acid, which contains the necessary oxidation equivalent to decompose to 
another equivalent of water and the thioaldehyde. Hydrolysis of this, finally yields the aldehyde 
containing product.   
The direct reaction of oxygen with the FGE cysteine, however, is thermodynamically not 
 
  
Fig. 2-7: Active site view of human FGE (PDB code 2AIK) with Cys341 and Cys15 being involved in copper binding. 
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Scheme 2-8: Proposed mechanism of fGly formation without participation of cofactors. The proposed disulfide bond 
intermediate was observed in crystal structures. 
favorable.[57] Single electron transfer from sulfur to oxygen leads to the generation of two 
unstable product (superoxide ion and HS∙). A two electron transfer would be thermodynamically 
possible, but the presence of two unpaired electrons in the highest occupied orbitals of 3O2 (see 
Fig. 2-1) that are similar in energy disfavours this process. The mechanisms hence required 
additional investigation to solve the riddle about oxygen activation. 
The participation of metal ions has been excluded due to absence of iron, copper or zinc in 
purified protein preperations.[54] Even though traces of copper were found to be present in some 
cases (0.09 mol/mol FGE) enzyme samples which have been supplied with additional copper 
proved to be inactive.[45] However, according to the previous remarks, oxygen activation can only 
be achieved if a suitable electron donor is present. We therefore anticipated, that the 
mechanistic proposals do not reflect the complete truth of FGE catalysis.   
Upon reinvestigation of the metal dependency of FGE we showed, that reactivity in the presence 
of copper largely exceeds the previously observed reaction rates.[64] The mechanistic proposal 
was then extended with the presence of copper (see Scheme 2-9). The resting state of the 
enzyme shows a disulfide bond in the active site, which in a first step will be reduced by a 
suitable reducing agent (in vitro often DTT). Reduced FGE is then able to bind copper(I), which 
afterwards has an open coordination site for oxygen to coordinate. This copper complex then 
transfers a single electron to dioxygen, generating the superoxide radical anion as well as Cu(II). 
O2
-∙ will then abstract an hydrogen atom from the substrate (similarly to other iron dependent 
FGEs[62]), which represents the rate limiting step. The substrate radical transfers an electron back 
to copper(II) yielding the thioaldehyde, which subsequently will hydrolyze to the fGly product. 
Hydrogen peroxide is not detectable in the reaction mixture, suggesting that oxygen is fully 
reduced to water.[65] One of the active site cysteines, attacks the peroxide anion to release a 
hydroxide and forms a sulfenic acid. This active form of FGE is then regenerated by reducion of 
the oxidized cysteine by the reducing agent present in solution.   
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Scheme 2-9: Mechanistic proposal of fGly formation under participation of copper as a cofactor. Binding of copper was 
shown in kinetic analyses. 
It has to be noted, that a second class of SAM dependent FGEs has been identified. While the 
substrate recognition motif is similar (only cysteine is replaced by serine), these FGEs are 
dependent on an iron sulfur cluster as electron donor as well as SAM for hydrogen atom 
abstraction of the substrate, but catalyze the fGly formation in the absence of oxygen. Hence the 
mechanisms happen to be unrelated to the one discussed here.[62][63] 
The proposed reaction cycle shows various similarities to the LPMO-catalyzed oxidation. Firstly, 
oxygen activation occurs in a initial step, by electron transfer from copper(I) to oxygen and 
generation of the couprous intermediate. Also, hydrogen atom abstraction has been shown to be 
the key step in the reaction and last but not least, the requirement of an external reducing agent. 
The reducing agent in the catalytic cycle of LPMOs was proposed to be a complex electron donor 
system.[71] In contrast, the reducing agent which is involved in the FGE reactivation in vivo is yet 
to be identified.    
While there are differences in the mechanistic details, further comparisons between these two 
very distinct classes of oxygenases can most likely be drawn in the future, which will be of 
advantage for researchers working in both fields. 
Again, LPMOs and FGE share similarities not only on the mechanistic level. The importance of 
LMPO for the biorefinery has been outlined before. Likewise, FGE has gained compelling interest 
in biotechnology as it opened up new possibilities to site-specifically introduce aldehyde 
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functionalities into virtually any recombinant protein. The defined recognition motif has been 
genetically introduced into recombinant proteins of interest upon which FGE catalyzed aldehyde 
formation is followed by chemical ligation techniques to introduce virtually any chemical 
label.[5][58]   
 
2.4 Bioconjucation  
Ever since enzymes were first identified and isolated researchers have reached out to utilize the 
potential of biocatalysts to facilitate or simplify industrial processes. Shortly after the discovery of 
diastase, a starch hydrolising enzyme discovered in the 1830s, first applications have emerged 
mostly to produce dextrin.[72] With the industrial revolution and medicinal and biochemical 
science fastly expanding the field of enzymology, other, more complex, applications emerged. 
The first enzymatic synthesis of isomaltose was developed in 1898 by Croft-Hill in which he 
reacted a yeast extract with a glucose solution.[73] Today enzymes are used in organic synthesis, in 
fermentations and to generate new functionalyzed materials.[74][75][80]  
Bioconjugation is the ‘simple’ attachment of one molecule to another via a new covalent bond in 
which one of the two conjugates originates from a biological source or displays a biological 
function. Examples range from the attachment of fluorescent labels to antibodies, which in turn 
bind their specific antigen and hence enable visual input of their binding locus, to surface 
localized affinity ligands or even enzymes, which can perform catalysis on a solid surface.[76] The 
newly formed bond typically is formed by the use of a linker moiety which displays two distinct 
reactive groups on either side, enabling different chemistry to form covalent bonds (see Fig. 2-8). 
Examples for covalent attachment are the carbon-sulfur bond between maleimid and protein 
cysteins or esters of N-hydroxysuccinimid groups which can be displaced by lysine residues. 
While the designs shown in Fig. 2-8 provide good methods for interlinking proteins or labels, 
some do require extensive synthesis. Others are less demanding with regards to synthesis, but 
show other disadvantages like the lack of regio specificity.  
In search of an easy to install and selective linker to combine any protein of interest with virtually 
any tag, researchers have reached out to utilize the remarkable reactivity of the formylglycine 
generating enzyme to generate a non-proteinogenic and thereby unique amino acid on the target 
protein, which can be covalently linked in a subsequent step. A sequence comparison of 
sulfatases from different organisms revealed that FGE recognizes a defined amino acid motif 
(with CxPxR being highly conserved).[78] However, little later it was shown, that replacement of 
proline or arginine by alanine, likewise leads to the formylglycine containing protein, indicating 
that the recognition motif is more flexible (at least when using FGE from E.coli).[79] The amino 
acid sequence can genetically be introduced into the structure of recombinant proteins, which 
will then be recognized by FGE. Upon coexpression with FGE in E.Coli the tagged proteins can be 
isolated with the aldehyde being installed at high conversion rates. After protein purification the 
aldehyde containing protein is reacted with hydroxylamines or hydrazines to yield the labeled 
protein. While initial setups were limited to C- or N-terminal modification, other designs with 
slightly extended recognition sites yield the formylglycine insertion into internal loop regions of 
for example GFP or even antibodies.[80][81] In addion to protein labeling with fluorophores others 
have demonstrated that formylglycine containing proteins can efficiently be imobilized on 
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nanocellulose or agarose.[80][82] With no doubt, FGE catalyzed aldehyde formation has found its 
way into current biotechnological methodologies.  
 
 
 
 
Fig. 2-8: Different approaches to covalently link proteins or enzymes to other proteins, surfaces or functionalization 
tags. A: The reaction of maleimides with surface exposed cysteines and the replacement of N-hydroxysuccinimids by 
lysine residues. B: Silane decorated epoxide building blocks are immobilized on surfaces and subsequently attacked by 
lysine residues of the target protein.[77] C: 2-iminothiolane  is used to covalently link lysines and cysteines. D: 
Selective oxidation of a defined cysteine residue to an aldehyde functionality is followed by chemical ligation with 
hydroxylamines. 
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3. Aim of this Thesis 
xygen activation in FGE has been unexplained since the first discovery of the enzyme in 
1995.[4] The most important residues in the active site have been identified as two 
conserved cysteine residues.[48]  While initial mechanistic pathways were proposed based on 
structural observation, detailed biochemical investigations of the reaction mechanism were not 
available.   
The identification and quantification of side products is vital for the understanding of the 
mechanism of a reaction. One first goal of this work was therefore to provide detailed 
investigations of the reaction stoichiometries.  
Furthermore, the direct electron transfer of sulfur to oxygen as discussed before is not 
favourable. Consequently, one aim of this work was to elucidate how oxygen activation can occur 
in FGE eventhough no cofactors were believed to participate in the reaction. The identification of 
potentially overlooked cofactors and the investigation of their method of action is an essential 
part of this assessment.   
FGE from T. curvata shows low activity at standard conditions in vitro. In an attempt to improve 
biotechnological applications, we furthermore assay possibilities to improve the utility of FGE for 
in vitro labeling reactions of recombinant proteins.  
O
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4. Formylglycine Formation – A Copper Dependent Reaction 
xygen activation requires the transition of oxygen from a triplet to singlet state (see chapter 
2.1). While enzymes such as cytochrome P450s or polysaccaride monooxygenases use metal 
centres to achieve electron transfer towards molecular oxygen, others (i.e. flavoproteins) have 
evolved cofactor dependent mechanisms, in which radicals stabilized on organic cofactors can 
then react with molecular oxygen.  
The formylglycine generating enzyme has been described as a metal- and cofactor-independent 
monooxygenase. While other cofactor-independent enzymes that use oxygen as a terminal 
electron acceptor are known, FGE is a special case since its active site contains only proteogenic 
amino acid functional groups and lacks any polyaromatic moieties that are typically involved in 
cofactor independent oxidases and oxygenases. The two most important residues in FGE catalysis 
have been identified as two highly conserved cysteine residues at the end of a substrate binding 
groove. While spontaneous reaction of thiols with oxygen can be observed in many biochemical 
reactions, this type of oxidation typically leads to oxidized sulfur species such as disulfides or 
sulfenic acids.   
Mechanistic proposals for how the FGE catalyzed aldehyde formation occurs previously 
contained the formation of a mixed disulfide with the substrate. This was followed by the formal 
addition of O2 and subsequent reduction to the sulfenic acid. The details of how sulfur mediated 
oxygen activation should occur, however, have remained unsolved. Direct reaction of a cysteine 
residue with molecular oxygen is a spin forbidden process. In contrast, thiols often show high 
affinities to metal ions, such as zinc or copper. We therefore propose that the mechanistic 
hypothesese outlined prior to this work did not resemble the complete truth of FGE catalysis and 
might lack one key element that can explain the observed oxidation reaction with the substrate. 
  
In the following chapter we show that FGE catalysis requires equimolar amounts of reducing 
agents and that hydrogen sulfide is released in quantitative amounts. Furthermore the 
dependency of FGE catalysis on copper(I) is demonstrated.   
 
4.1 In vitro Reconstitution of FGE with Copper(I) 
4.1.1  Establishing a robust study system 
To further advance FGE research, we selected an FGE variant from Thermonomospora curvata, an 
organism first isolated from stable manure, and known to prefer elevated temperatures.[86] The 
selected variant shares 58 % sequence homology with the human variant (FGEhuman). Conclusions 
made for FGE from T. curvata should thereby allow for comparisons with the FGEhuman. Similarly, 
published data obtained for FGE from H. sapiens and S. coelicolor should also be applicable to our 
research (sequence homology of FGE from curvata to the streptomycese protein is 64 %). 
Working with proteins from thermostable organisms can have the advantage of potentially 
higher production and isolation yields and higher resistance towards thermal stress. This in turn 
can broaden the spectrum of possible applications for later use in biotechnology. Indeed, E. coli 
cell cultures in shaking flasks yield good amounts of 5 – 10 mg/L purified protein sample 
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Fig. 4-1: Left: SDS-PAGE picture of FGE
weight marker; B: FGEWT; C: FGEWT + DTT. 
protein peak (a) as well as a glycosylation adduct on the His
MWobs,WT = 35306.5 Da. Right: Determination of temperature 
diluted to a concentration of cFGE = 10 µM in a buffer containing 2
while heating at 1 °C/min. 
 (see Fig. 4-1) after purification by Ni
20 - 30 mg/L of medium when performing a controlled fermentation production. The 
spectra of FGE from T. curvata (FGE
shows the expected mass after cleavage of the initial methionine (MW
MWobs,WT = 35306.5 Da). The observed mass difference of ΔMW
formation of a disulfide bond within the protein structure. During 
protein preparation is active in the
as a reducing agent.[3] Moreover, the protein is stable up to a temperature of T
no sign of thermal unfolding and an activity maximum at a temperature of 
pH optimum of around 10-11 (see appendix 
determined using a synthetic peptide 
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Fig. 4-2: Product identification by HPLC using the specific absorbance of the Abz group at λ
catalyzed aldehyde formation is followed by acid catalyzed schiff base formation. The aldehyde product is not 
observed. Bottom: Representative HPLC chromatogramm showing the oxidized DTT (a), the substrate peak (b) and the 
product peak (Schiff base, c, MWcalc,schiff base
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encoding the recognition motif CxPxR (peptide sequence: Abz-SALCSPTRA-NH2). After aldehyde 
formation, the product undergoes acid catalyzed Schiff base formation with the ortho amino 
group of the terminal Abz group further facilitating peak separation (see Fig. 3-2). 
4.1.2   Analysis of the FGE catalyzed reaction  
The main consensus about the mechanism of FGE is that the two highly conserved active site 
cysteines are involved. The reactivity of protein sulfur groups is largely determined by their redox 
state, hence our concerns lied with the oxidation state of the two active site cysteines. Crystal 
structures of the FGE from H. sapiens and S. coelicolor contain a disulfide bond between the two 
active site cysteines. In order to simplify the FGE system and to avoid disulfide shuffling side 
effects we constructued a FGE variant in which all cysteines, aside from the active site residues, 
are mutated to either alanine or seine (FGEC187A,C231A,C284S,C298A = FGE4C). The variant is readily 
producible in BL-21 E. Coli cells. The protein yields however, happen to be lower (m4C = 2 mg/L of 
culture vs. mWT = 6 mg/L of culture) which is to be expected after introduction of four mutations 
into the protein structure. Regardless of the lower yields, the isolated protein sample gave the 
expected mass in HRMS measurements (MWcalc,4C = 35195.8 Da; MWobs,4C = 35193.8 Da), again 
indicating the absence of a cofactor or bound metals. With regards to the activity of the new 
variant we did observe an unexpected increase in reactivity under the standard conditions. The 
catalytic efficiency increased to kcat/KM,4C = 1000 M
-1min-1 (see kcat/KM,WT = 100 M
-1min-1).   
With the new variant FGE4C containing only the two cysteines residues involved in the reaction, 
we were now able to selectively address their redox state by chemical means. We used two 
published assays to quantify the amount of free thiols and disulfide bonds in FGE from T. curvata 
(see Tab. 4-1). The active site cysteines were found to be oxidized which is in good agreement 
with published crystal structures[56][54] as well as the mass increment of ΔMW = -2 Da in HRMS 
measurements. Alkylation attempts of FGE4C using 2-iodoacetamide (IAA) did not result in the 
labeled active site cysteines unless these were previously reduced by addition of DTT. This 
observation provides further evidence that the cysteines exist in an oxidized state (see Tab. 4-1).
  
Researchers have previously observed the dependence of FGE activity upon the addition of thiols 
in vitro.[3] In order to gain a complete understanding of the details of FGE catalysis, we quantified 
this correlation. Even in absence of FGE the oxidation of DTT is significant (see Fig. 4-3). However, 
during turnover the consumption of reduced DTT is enhanced. When comparing the rates of 
product formation, consumption of substrate and DTT oxidation, we   
 
Tab. 4-1: Thiol and disulfide content of FGE from T. curvata determined using Ellmann’s reagent[92][93] and the degree 
of alkylation after treatment of FGE4C with 2-iodo acetamide. 
[a]not determined 
 SH/FGE (SH + S-S)/FGE IAA adducts 
FGEWT 4.3 ± 0.2 3.8 ± 0.2 - 
[a] 
FGE4C 0.4 ± 0.2 1.3 ± 0.1 0 
FGE4C + DTT - 
[a] - [a] 2 
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Fig. 4-3:  Left: Rates of spontaneous or FGE catlyzed DTT oxidation. In the absence of substrate the DTT oxidation rate 
is low. Only in the presence of substrate and even more under steady state conditions during conversion, DTT 
consumption is substantial. The asterisk  (column 5) indicates the DTT oxidation rate during turnover corrected by 
substraction of the background oxidation determined in the absence of FGE. Middle: Requirement of reducing agent. 
Product formation during the FGE4C catalyzed reaction in the absence of reducing agent is slow. Only upon addition of 
reducing agent the reaction rate increases, with GSH not having an effect. (cFGE = 0.5 µM, cCu(I) = 0.5 µM, 
csubstrate = 50 µM). Right: Rates of substrate consumption (a) and product formation (d) as well as the rate of DTT 
oxidation without (b) and with background correction (c, dashed). 
observe a correlation between these three rates (Fig. 4-3, right), indicating turnover dependent 
oxidation of reducing agent. Indeed, in the absence of reducing agent FGE activity is reduced by 
50 fold. Upon addition of reducing agents like DTT and cysteamine (2-aminoethane-1-thiol) to 
this reaction the reactivity is restored to full reactivity (see Fig. 4-3, middle). When using larger 
thiols (i.e. glutathione) or a non-thiol reducing agent (i.e. TCEP) the product formation remains 
slow (see also Appendix Fig. 4-14).     
In order to further analyze the FGE catalyzed reaction, we then tried to identify other products 
aside the formylglycine residue. It has been previously stated that oxidation of the cysteine 
residue to the thioaldehyde is followed by hydrolysis to fGly. However, direct evidence for the 
detection of hydrogen sulfide (H2S) is missing. We therefore used a published assay to quantify 
the amount of H2S released during turnover. We show the stoichiometric formation of H2S and 
fGly (Fig. 4-4 bottom left, e and d) in the course of the FGE catalyzed reaction. This further  
 
 
 
  
Fig. 4-4: Top: FGE catalyzed oxidation of the substrate cysteine to a thiol aldehyde and subsequent spontaneous 
hydrolysis to the aldehyde moiety and hydrogen sulfide.  Bottom left: Quantification of H2S formation. FGE catalyzed 
product formation is coupled to H2S formation. In the absence of or presence of only substrate or FGE no hydrogen 
sulfide is formed (a-c). Upon mixing of substrate and FGE in the presence of DTT the product formation (d) and release 
of hydrogen sulfide (e) are correlated (cFGE = 1 µM, csubstrate = 100 µM). Bottom right: Rates of product formation and 
release of hydrogen sulfide under various conditions. 
  
27 
 
indicates that the sulfur atom of the substrate is not irreversibly oxidized.   
The reduction of oxygen to water requires four electrons. Two of these electrons are provided by 
the substrate which gets oxidized. The remaining two are provided by the reducing agent which is 
stoichiometrically consumed. In agreement with these observations,  H2O2 (a theoretically 
possible product derived from molecular oxygen) is not detectable.[65] 
4.1.3  Metal dependent activity of FGE 
After having quantified the side-products of the FGE-catalyzed reaction, the rational of how 
oxygen activation can occur by the active site cysteines, still remains unclear. One possible 
explanation is the absence of a redox-active cofactor. Investigations of the metal content of 
isolated FGE were performed previously. Analysis via ICP-MS showed the presence of calcium as 
well as potassium (1.65 and 0.69 mol/mol FGE, respectively) in samples of human FGE.[45] A 
different study analyzing bacterial FGE from Streptomyces coelicolor and Mycobacterium 
tuberculosis identifies one Ca2+ in the S. coelicolor variant, while FGE from M. tuberculosis did not 
contain significant amount of metals.[54] The residues involved in calcium binding, however, are 
highly conserved within FGEs. While such alkali and alkaline earth metals do not suffice to 
catalyze redox chemistry, they might contribute to protein stability and folding or serve as a 
Lewis acids. However, the absence of such metals in (still active) FGE from M. tuberculosis leads 
to the conclusion that these metals are not essential for in vitro turnover. Interestingly, human 
enzyme preperations were found to contain 0.09 mole of copper per mole of FGE. Upon 
supplementation of the reaction buffer with excess of Cu(II)Cl2 (Cu : FGE 1000 : 1) FGE was 
strongly inhibited (IC50 ≈ 5 µM).
[45] The effect of heavy metals on protein folding and stability has 
been subject to many research projects and it is well recognized that such metals can be toxic 
towards many organisms.[89][90] In fact, protein aggregation and inactivation can be caused by 
large amounts of transition metals in the medium.   
With this in mind, we intended to reinvestigate the previously published data by assaying the 
rate of product formation in the presence of various metal salts. Interestingly, the conversion 
rates were found to be significantly higher in cases in which the reaction buffer was 
supplemented with one mole of copper per mole of FGE (reaction rate enhancement of 10 fold, 
 
   
Fig. 4-5: FGE is a copper dependent oxidase. Left: Relative reaction rates in the presence of different metal salts. 
FGEWT. Only copper salts accelerated the FGE catalyzed reaction, while others have no effect on the reaction or have an 
inhibitory effect. Middle: Crystal structure of FGE from H. sapiens (PDB 1Y1E, 1.7 Å). Shown are the two cysteines that 
have been identified as beeing essential for catalysis and the distance between their alpha carbon. Right: Crystal 
structure of Atx1 from H. sapiens (PDB 1FEE, 1.8 Å). Shown are the two cysteines involved in copper binding and the 
distance between there αC as well as a copper atom. 
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see Fig. 4-5, left). Importantly, none of the other metals showed a comparable effect, which 
suggests a potential role for copper as a redox active metal rather than serving as a Lewis acid or 
providing structural support. Not only does the presence of copper increase the kcat of FGEWT, it 
was also found to lower the KM value. While we were not able to saturate the enzyme with 
substrate in the absence of copper (up to a substrate concentration of [Substrate] = 1000 µM), 
addition of copper decreased the KM to KM,WT = 580 ± 40 µM. When analyzing FGE4C, copper 
dependent increase in reactivity was observed similarly to the wild type reaction. Again, after the 
addition of copper the reaction rate increased by 10-fold (see Fig. 4-6) and the catalytic efficiency 
was increased by 20-fold (kcat/KM,4C-Cu = 1000 M
-1min-1 vs. kcat/KM,4C+Cu = 20000 M
-1min-1). This is 
attributed to the lower KM value which is, similar to FGEWT, also observed for FGE4C (no copper: 
KM,4C = 600 µM; with copper: KM,4C = 200 µM). The higher catalytic efficiency is thereby combined 
result of the higher kcat and the lower KM.   
In addition to the metal, enzyme and substrate the reaction buffer contained EDTA as a chelating 
agent for any excess metal ions, as well as DTT as a reducing agent. EDTA mostly binds Cu2+ with a 
stability constant of KD = 10
-18 M but does not bind Cu+.[91] In contrast, DTT with its low redox 
potential of -0.33 V (against SHE) will quickly reduce any Cu2+ to Cu+ (+0.35 V). We therefore 
believe, that the active species in solution is best described as being Cu(I) and the elevated 
reaction rate after addition of Cu(II) is a result of the immediate reduction of Cu(II) to Cu(I) which 
will then interact with FGE.   
Copper(I) and copper(II) are both often found in redox active enzymes (see also chapter 2.2), but 
require different binding sites. In fact, when analyzing the FGE active site for possible copper 
binding sites, one can identify similarities between FGE and Cu(I) binding proteins such as Atx1 
(see Fig. 4-5 and chapter 2.2). Analogous to Atx1 FGE also provides two cysteine residues in the 
active site. When taking the carbonyl carbon as a reference, the two appear to be 5.4 Å (PDB ID: 
1Y1E, 1.7 Å resolution) apart while the two cysteines in the copper chaperon are located within a 
distance of 5.2 Å (PDB ID: 1FEE, 1.8 Å resolution). Since the cysteines in Atx1 provide excelent 
copper binding capabilities, these structural similarities might explain copper binding also in FGE. 
Arguably, the disulfide bond in the human crystal structure might force the cysteines into this 
tight conformation, however in the structure of FGEC336S with bound substrate, the introduced  
 
   
Fig. 4-6: Left: Rates of product formation using different FGE variants. FGEWT as well as FGE4C are likewise activated by 
addition of copper. Middle: Copper concentration required to saturate increasing amounts of FGE4C. The reaction rates 
at different concentrations of FGE were assayed each at increasing copper concentrations. The lowest concentration of 
copper yielding the highest reaction rate was plotted against the respective FGE concentration. The data was fitted 
with a linear plot. The slope of which is close to 1 µM Cu/µM FGE, indicating the 1 : 1 relationship between metal and 
enzyme. Right: Increase in reaction rates of FGE from Mycobacterium smegmatis and Thermomonospora curvata upon 
coppper treatment. 
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and remaining cysteine (now engaged in a disulfide bond with the substrate) are seperated by a 
distance of 5.5 Å (PDB ID: 2AIK, 1.73 Å).  
We then further investigated whether copper forms a complex with FGE or rather provides a 
source of reactive oxygen species in solution which could then interact with the enzyme. To do 
so, we analyzed the reaction rate of FGE4C in the presence of increasing amounts of copper and 
determined the amount of copper required for maximal activity (see also Appendix Fig. 4-13). 
After doing so for various concentrations of FGE we observed a correlation between copper 
concentration required for saturation and the enzyme concentration (see Fig. 4-6, middle). The 
slope of the linear fit is m = 1, showing that one copper ion is required to activate one molecule 
of FGE. This favours the hypothesis, that copper forms a complex with FGE, and excess of copper 
does not further contribute to the reaction after FGE saturation with copper. We therefore 
conclude that the observed effect is not a results of an increased concentration of ROS in solution 
(by copper catalyzed reduction), but of the formation of a complex between FGE and the metal. 
  
To verify that copper dependent rate acceleration is not just an erratic feature of this particular 
homologue, we cloned a FGE variant from Mycobacterium smegmatis (FGEsmegmatis) and analyzed 
the reaction rate in the presence of copper(I). The two proteins both originate from 
actinobacteria but share a sequence homolgy of only 46 %. Despite this low homology, both 
proteins show higher reaction rates in the presence of one equivalent of copper (see Fig. 4-6, 
right). In fact, in an unrooted phylogenetic tree (see Fig. 4-7, left), the two proteins are located on 
opposite branches, with the human variant (FGEhuman) being more closely related to FGEWT from 
T. curvata (sequence homology 58 %). The fact, that the copper dependent rate acceleration is 
observable for two distantly related homologues, such as FGEWT and FGEsmegmatis, suggests that 
copper dependent rate acceleration should also be observable for other FGEs. In fact, the copper 
activation has additionally been shown for FGE from Streptomyces coelicolor and Homo sapiens, 
further supporting the relevance of copper mediated activation of FGE.[94] However when similar 
  
   
Fig. 4-7: Left: Unrooted phylogenetic tree showing the relaction between FGEs from different organisms. Selected 
were the closest FGE homologues in 15 bacterial phyla and H. sapiens. FGEs from the following organisms have been 
considered: Gemmatimonadetes bacterium KBS708, Entomoplasma somnilux , Homo sapiens, Gluconobacter oxydans, 
Opitutaceae bacterium TAV5, Phycisphaeramikurensis, Acidobacteriaceae bacterium TAA166, thermomonospora 
curvata, Bhargavaeacecembensis DSE10, Deferribacter desulfuricans, Chlorogloeopsis fritschii, Thermophagus 
xiamenensis, Parachlamydiaa canthamoebae, Leptospira meyeri serovar Hardjo str. Went 5, Mycobacterium 
smegmatis, Deinococcus deserti. Right: Reaction rate of FGEWT and FGEhuman in the presence of copper. Increased 
reactivity is observed only for FGEWT while FGEhuman shows comparable activity to the copper free reaction. The active 
site of FGEhuman might be preloaded with copper from the culture medium. 
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reactions with FGEhuman were performed in our laboratory, we did not observe an enhanced 
reaction rate in the presence of copper (see Fig. 4-7). We concluded that the enzyme might be 
preloaded with copper from the expression medium and is therefore not activated by additional 
copper.  
The identification of copper as an important cofactor for FGE catalysis, we then further 
investigated copper induced structural effects. While the structure consists largely of random coil 
(see chapter 2.3.3), analysis of the CD spectrum before and after addition of copper shows an 
increase in the alpha helical content (see Fig. 4-8, left). In the presence of copper, the point of 
thermal unfolding is significantly shifted towards higher temperatures (ΔT > 15 °C, see Fig. 4-8, 
left). The graph shows two transition points. A minor one, only contributing to ≈ 10 % of the 
unfolding (based on the overall change in elipticity) and the global unfolding, responsible for the 
major loss of CD signal. The first minor transition is initiated at temperature comparable to those 
of the global transition in the copper free sample (60 – 70 °C). The second, major transition in the 
FGE:Cu complex however occurs at significantly higher temperatures. We hypothesize, that a 
smaller, less stable loop is prone to denature at lower temperatures (T < 80 °C) whereas the core 
of the protein is highly stabilized upon addition of copper with global denaturing occuring only at 
temperatures higher than 80 °C. A similar copper induced stabilization has been observed for 
metallo chaperons CopZ from Bacillus subtilis and Atox1 from Homo sapiens.[95] Both proteins 
share the copper binding motif MxCxxC and the denaturation temperature in the presence of 
copper increases by ΔT = 3 - 10 °C. While the copper binding site is located on a surface exposed 
loop region, it has been suggested that copper binding induces rearangements throughout the 
protein structure which enhances the core stability. In contrast, other examples exist in which 
copper was shown to enhance the rate of proteolysis of CopZ from Enterococcus hirae, which in 
turn displays the toxicity of elevated copper concentrations in vivo.[96]  
The enhanced reactivity of FGE in the presence of copper not only enables researchers to 
improve existing protein labeling methods, but also proves to be of particular importance in the 
understanding of the FGE mechanism. Previous studies have suggested a potential mechanism, 
but to some extent rely on assumptions and do not specifiy on the way of oxygen activation. The 
finding, that FGE activity relies on a redox active metal centre explains for the first time how 
oxygen activation can occur.   
To further investigate the mechanism of action of FGE we determined the rate limiting step of 
the reaction. We therefore synthesized a deuterated substrate peptide with a deuterium atom in 
position of the (R)-β-hydrogen (see Scheme 4-1). When supplying the reaction with the  
 
  
Fig. 4-8: Circular dichroism analysis of FGEWT in the presence of copper. Cu(I) binding induces an increase in helical 
content (left) as well as an increased resistance towards thermal stress (right).  
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Scheme 4-1: Reaction scheme showing the selective removal of the (R)-β-hydrogen of the substrate cysteine in the 
course of the FGE catalyzed reaction. 
deuterated peptide analog the reaction rate of FGEWT and FGE4C in the absence of copper is not 
affected (kH/kD = 0.8 - 1.2). In the presence of copper, however, the rate of product formation 
shows a substrate kinetic isotope effect (KIE) of KIEWT = 3.7 ± 0.2 and KIE4C = 3.0 ± 0.2. The 
products of both, the non-deuterated and the deuterated substrate, share the same mass as well 
as isotope pattern (see Appendix Fig. 4-15), indicating loss of the deuterium during turnover. The 
isotope effect proved to be independent of the substrate concentration (see Fig. 4-9). We 
therefore conclude that the presence of copper increases the extent to which hydrogen 
abstraction from the substrate is rate limiting. To further support this finding we additionally 
tested for isotope effects when using human FGE. In agreement with the data obtained with 
FGEWT and FGE4C, copper-supplemented FGEhuman shows an isotope effect of KIEhuman = 4.0 ± 0.1. 
In contrast to the previous observations with FGEWT, FGEhuman shows an isotope effect of 
KIEhuman,-Cu = 3.9 ± 0.1 even in the absence of copper. In agreement with our earlier observation 
that copper addition does not positively influence the reaction rate, one can interpret the human 
variant as being preloaded with copper, already after isolation from the expression system. The 
isotope effect without the presence of copper can hence not be determined without removal of 
the metal. Efficient methods to remove the metal and sustain the activity are yet to be 
developed. However, what remains is the observation that both FGEWT as well as FGEhuman share 
the same rate limiting step, indicating that both variants follow the same reaction scheme and 
that mechanistic findings of FGEWT will hold true also for the human enzyme.   
 
 
  
Fig. 4-9: Left: The substrate kinetic isotope effect at increasing substrate concentration. The reaction mixture was 
supplied with FGEWT and one molar equivalent of copper. Right: The isotope effect of FGEhuman in the presence and 
absence of copper is indistinguishable as FGEhuman is already preloaded with copper. 
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4.2 Conclusion 
Copper dependent oxidation reactions have been known for many years. The participation of 
copper ions in the FGE mechanism, however, has been excluded until recently due to the 
absence of metals in protein preparations and accordingly crystal structures.[45] While residual 
copper (0.09 Cu/FGE) was previously identified in some FGE samples isolated from eukaryotic cell 
lines, the reactivity of such enzymes in the presence of copper decreased. In contrast our present 
results show the rate enhancement of FGE upon incubation with one molar equivalent of Cu(I). 
Interestingly, the reaction rate of FGEWT in the absence of additional metal is 6 % of the maximum 
reactivity that we observe under standard conditions with copper present (vWT-Cu = 0.01 min
-1 vs. 
vWT+Cu = 0.17 min
-1). The low activity might therefore be a representation of the low copper 
loading, with metal independent turnover not being possible. The inhibitory effect of copper 
previously reported by other researchers could be attributed to the large excess (1000 fold) of 
copper during the setup of the reaction.[45] The toxic effects of copper as well as metal catalyzed 
formation of reactive oxygen species on cells and proteins is well established.[7][42] We therefore 
demonstrated the requirement of a 1:1 ratio between copper and FGE to yield the highest 
activity. The requirement of copper for catalysis was additionally demonstrated for a second 
bacterial protein (M. Smegmatis) showing the generality of this observation. The work of other 
research groups, who likewise observed the copper mediated rate enhancement in vitro and in 
vivo further support our findings.[94][97]   
In addition to the participation of copper(I) in FGE catalysis we demonstrated the stoichiometric 
release of hydrogen sulfide as well as the first quantitative analysis of reducing agent 
consumption during turnover. Although, the requirement of reducing agents has been reported 
by others prior to this work[3] quantification has lacked.  
For the first time, the equimolar release of H2S and the quantitative consumption of reducing 
agent have been demonstrated. We therefore suggest that the oxidation equivalent of molecular 
oxygen is transfered to the substrate and the reducing agent, rather than being released in 
hydrogen peroxide. In agreement with this observation, H2O2 has not been detected during 
turnover.[65]   
The finding that FGE requires copper for catalysis has furhter enriched the mechanistic discussion 
and resulted in the identification of the C-H bond cleavage as the rate limiting step. It also 
stimulates the development of FGE based bioconjugation applications, since in vitro and in vivo 
reactivity of FGE is significantly increased.[97] Together with the more stable protein fold this will 
most certainly support the development of new methodologies in biotechnology as it helps to 
overcome current limitations regarding low reactivity.   
The lysosomal storage disorder MSD has been attributed to insufficient FGE activity. Different 
gene mutations and deletions in the sulfatase modifying factor 1 gene have been identified.[48][98] 
The question might be raised, whether incomplete copper loading of FGE causes MSD or whether 
mutations on the FGE gene lead to insufficient metal binding. Similarly, proteins involved in 
copper delivery and transport such as the metallo chaperon Atx1 may contribute to the 
disfunction of sulfatases. In this light, the identification of copper as an essential contributor to 
FGE activity will further drive researchers to investigate the role of formylglycine related diseases 
such as MSD.   
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Protein identity was confirmed by SDS-PAGE and HRMS (see Fig. 4-10 and Tab. 4-2).  
Samples of FGEhuman were kindly supplied by Prof. Dr. Thomas Dierks, University of Bielefeld. 
 
Tab. 4-2: Calculated and observed molecular weights of proteins described in chapter 4 with comments on the mass 
difference. 
Protein MWcalc [Da] MWobs [Da] Comment 
FGEWT 35308.1 35306.5 Disulfide bond 
FGE4C 35195.8 35193.8 Disulfide bond 
FGEsmegmatis 44637.8 44633.4 Disulfide bonds 
 
Determination of thermal unfolding by circular dichroism. FGE was diluted to a final 
concentration of cFGE = 10 µM in a buffer containing 50 mM Tris, 50 mM NaCl and 2 mM DTT. 
Thermal unfolding was monitored at λCD = 222 nm in a quartz cuvette of 1 mm pathlength while 
heating at 1 °C/min in steps of 1 °C. Data points were fitted with a boltzman distribution curve 
(see Eq. 2) with x0 being the midpoint of thermal transition. 
    =  + 	
  
  (2) 
Peptide synthesis. Peptide substrates were synthesized by Fmoc solid phase peptide synthesis 
following standard protocols on a peptide synthesizer. Shortly, the most C-terminal amino acid 
was coupled to Rink amide resin. Deprotection of the primary amine is accomplished by 
incubation with 40 % piperidine in DMF. The subsequent amino acid is added and activated by 
HCTU in DMF upon which coupling occurs. Unreacted peptide is quenched by addition of acetic 
anhydride DMF. The peptide is sequentially synthesized with the last step being coupling of 2-
amino benzoic acid. Cleavage from the resin and deprotection of the amino acid side chains is 
simultaneously achieved by incubation with the cleavage cocktail (TFA:TIPS:DCM  96.5 : 2.5 : 1) 
for 3 hrs. Impurities have been removed by RP-HPLC after which lyophilization yields the final 
peptide substrate. The identity of the peptide was confirmed by ESI-MS (sequence: Abz-
SALCSPTRA-NH2; MWcalc = 1023.5 Da, [M+H]
+
obs = 1024.5 Da, [M+2H]
2+
obs = 513.0 Da).   
The deuterated peptide analog was kindly supplied by Pascal Engi. 
Analysis of reaction rates. Reaction rates were determined using a discontinous HPLC assay. If 
not stated otherwise, FGE was diluted to a final concentration of cFGE = 2 µM in a reaction buffer 
containing 200 µM substrate peptide, 2 mM DTT, 50 mM EDTA, 50 mM NaCl and 50 mM Tris-HCl 
buffer pH 8. Samples containing additional metal salts were supplemented with the respective 
metal ion at a final concentration of cmetal = 2 µM. The reaction was incubated at Treact = 25 °C. 
Throughout the reaction time, samples were quenched by addition of one volume equivalent of 
4 M urea in 2 % TFA, which were subsequently analyzed by RP-HPLC (Gemini-NX, 5um C18 
250 x 4.6 mm column, gradient see Tab. 4-3, RTsubstrate = 10.8 min, RTproduct = 13.1 min). The 
substrate concentration was determined by comparison to a calibration curve established with 
free 2-amino benzoic acid. The product concentration was determined by comparison to a 
calibration curve established with samples of fixed product concentration (known substrate 
concentration after complete turnover).  
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Tab. 4-3: HPLC gradient used for the seperation of the substrate peptide and the product peptide of the FGE catalyzed 
reaction. Buffer A: H2O, 1 % MeCN, 0.1 % TFA. Buffer B: MeCN, 0.085 % TFA. Flow rate 1 mL/min. 
Time [min] Buffer B [%] 
0 15 
0.5 15 
12.0 20 
17.0 95 
20.7 95 
22.0 15 
25.0 Stop 
 
Michaelis Menten Kinetics. Reaction rates at increasing amounts of substrate were determined 
using a discontinous HPLC assay. FGE was diluted to a final concentration of cFGE = 2 µM in a 
reaction buffer containing 0 - 1000 µM substrate peptide, 5 mM DTT, 50 mM EDTA, 50 mM NaCl 
and 50 mM Tris-HCl buffer pH 8. Samples containing additional copper were supplemented with 
CuSO4 at a final concentration of cCu = 2 µM. The reaction was incubated at Treact = 25 °C. 
Throughout the reaction time, samples were quenched by addition of one volume equivalent of 
4 M urea in 2 % TFA, which were subsequently analyzed by RP-HPLC (see above). 
Analysis of thiol and disulfide content. The concentration of free thiols in samples of FGE was 
determined by following a known standard procedure.[92] Shortly, proteins were diluted in 8 M 
guanidine∙HCl to a final concentration of cFGE ≤ 40 µM upon which 0.2 volume equivalent of 
“buffer A” (100 mM boric acid, 0.2 mM EDTA) were added. Subsequently, 0.02 volume 
equivalents of a solution of 5,5’-dithiobis-2-nitrobenzoic acid (DTNB, cDTNB = 10 mM) wer added. 
After an incubation of tinc = 5 min the absorbance at λ = 412 nm was determined against a blank 
containing only buffer A and guanidine∙HCl (εDTNB,412 = 14150 M
-1cm-1).   
The concentration of free thiols was determined by comparison to a calibration curve established 
with samples of increasing amounts of L-cysteine. The concentration of disulfide bonds was 
determined following a known standard procedure.[93] Disodium 2-nitro-5-thiosulfoben-zoate 
(NTSB) stock solution was prepared by dissolving 70 mg of DTNB in an aqueous 10 M Na2SO3 
solution. Air was bubbled through the mixture until a pale yellow color was observed. The end 
point of the reaction was determined by absorbance measurement at λ = 412 nm (ε = 13900 
M-1cm-1). NTSB assay solution was prepared by diluting NTSB stock solution by 100 fold in “NTSB 
buffer” solution (Trizma base 2.228 g, guanidine∙HCl 28.659 g, EDTA (500 mM) 0.6 mL, Na2SO3 
1.2604 g, degassed H2O 100 mL, pH 9.5). Protein samples were prepared by dilution in NTSB 
assay solution and were kept in the dark. After incubation at RT for 5 min absorbance at λ = 412 
nm was measured against a blank containing only NTSB assay solution. The concentration of 
disulfide bonds is determined by comparison to a calibration curve established with samples of 
increasing amounts of L-cystine. 
Quantification of H2S formation. Hydrogen sulfide concentration was determined following a 
known procedure.[99] FGE was diluted to a final concentration of cFGE = 1 µM in a reaction mixture 
containing 100 µM substrate, 2 mM DTT, 50 mM NaCl and 50 mM Tris-HCl pH 8.0. After various 
time points, samples for sulfide analysis were quenched by addition of 0.08 volume equivalent of 
sulfide assay solution (10.8 mM N,N-dimethyl-p-phenylenediamine, 37 mM FeCl3 in 6 M HCl). 
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Sulfide formation was monitored by UV/vis spectroscopy after an incubation time of 20 min at a 
wavelength of λ = 667 nm. The concentration of H2S is determined by comparison to a calibration 
curve established with samples of increasing amounts of Na2S. 
Labeling with 2-iodo acetamide. FGE was diluted to a final concentration of cFGE = 45 µM in a 
reaction mixture containing 2 mM DTT, 50 mM EDTA, 50 mM NaCl and 50 mM Tris-HCl pH 8. The 
reaction was incubated at RT for 30 min, after which 2-iodo acetamide was added to a final 
concentration of cIAA = 5 mM. The reaction was then incubated at RT for 120 min. Protein 
modification was subsequently analyzed by LC/HRMS. 
Copper titration. The copper(I) saturation was determined by diluting FGE4C to a final 
concentration of cFGE = 0.5 – 10 µM in a reaction buffer containing 0 – 5 molar equivalents of 
CuSO4, 200 µM substrate, 2 mM DTT, 50 mM EDTA, 50 mM NaCl and 50 mM Tris-HCl pH 8. 
Reactions were then incubated at Treact = 25 °C. The reaction rates were determined as described 
previously (see above). 
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4.4 Appendix 
 
Fig. 4-11: Relative rate of product formation at increasing pH. FGEWT shows a pH optimum of pH 10 – 11. 
  
  
Fig. 4-12: Reaction rates of FGEWT (left) and FGE4C (right) at different substrate concentrations in the absence (solid 
square) and in the presence (empty square) of one molar equivalent of Cu∙EDTA. FGE was diluted to a final 
concentration of cFGE = 2 µM in a reaction mixture containing increasing amounts of substrate, 5 mM DTT, 50 mM 
EDTA, 50 mM NaCl and 50 mM Tris pH 8.0. Reactions in the presence of copper additionally contained 2 µM of CuSO4. 
Reaction was then incubated at Tinc = 25 °C. After various time points the reaction was quenched for product analysis 
by addition of 1 volume equivalent of 1 % TFA in 4 M urea. Product formation was analyzed by RP-HPLCfrom which the 
reaction rate has been calculated. 
 
 
Fig. 4-13: Reaction rates of FGE4C at different concentrations of copper. FGE was diluted to a final concentration of 
cFGE = 10 µM in a reaction mixture containing increasing amounts of copper, 200 µM substrate, 2 mM DTT, 50 mM 
EDTA, 50 mM NaCl and 50 mM TrispH 8.0. Reactions in the presence of copper additionally contained 2 µM of CuSO4. 
Reaction was then incubated at Tinc = 25 °C. After various time points the reaction was quenched for product analysis 
by addition of 1 volume equivalent of 1 % TFA in 4 M urea. Product formation was analyzed by RP-HPLC from which the 
reaction rate has been calculated. 
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Fig. 4-14: Relative activity of FGE in the presence of different reducing agents. FGE4Cwas diluted to a final concentration 
of cFGE = 0.5 µM in a reaction mixture containing 50 µM substrate, 0.5 µM CuSO4, 50 mM EDTA, 50 mM NaCl and 
50 mM Tris pH 8.0. Reducing agent was added after an incubation time of tinc = 40 min to a final concentration of 
creduce = 2 mM. Activity in the absence of reducing agent was calculated as average of the rates before addition of 
reducing agent. Positive controls were supplied with DTT at time t = 0 min. After various time points the reaction has 
been quenched for product analysis by addition of 1 volume equivalent of 1 % TFA in 4 M urea. Product formation has 
been analyzed by RP-HPLC. The relative rate has then been calculated, with respect to the control reaction which 
contained DTT from the beginning. 
 
 
Fig. 4-15: High resolution mass spectroscopy of the non-deuterated peptide substrate (a) and the selectively 
deuterated peptide substrate (c) and their respective products (b & d). Products were isolated by RP-HPLC after 
incubation with FGE overnight. 
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Tab. 4-4: Amino acid sequences of FGEs from different organisms described in chapter 4.  
Source Organism Sequence 
Thermomonospora 
curvata 
GSSHHHHHHSSGLVPRGSHMPSFDFDIPRRSPQEIAKGMVAIPGGTFRMGGEDPDAFPE
DGEGPVRTVRLSPFLIDRYAVSNRQFAAFVKATGYVTDAERYGWSFVFHAHVAPGTPVM
DAVVPEAPWWVAVPGAYWKAPEGPGSSITDRPNHPVVHVSWNDAVAYATWAGKRLPT
EAEWEMAARGGLDQARYPWGNELTPRGRHRCNIWQGTFPVHDTGEDGYTGTAPVNAF
APNGYGLYNVAGNVWEWCADWWSADWHATESPATRIDPRGPETGTARVTKGGSFLCH
ESYCNRYRVAARTCNTPDSSAAHTGFRCAADPL 
 
Mycobacterium 
smegmatis 
GSSHHHHHHGSDSEVNQEAKPEVKPEVKPETHINLKVSDGSSEIFFKIKKTTPLRRLMEAFA
KRQGKEMDSLRFLYDGIRIQADQTPEDLDMEDNDIIEAHREQIGGLTELVEVPGGSFRMG
STSFYPEEAPVHTATVGDFAIERHPVTNAQFAEFVEATGYVTVAERPLDPKLYPGVPEADLV
PGSLVFRPTSGPVDLRDWRQWWDWAPGACWHHPFGPRREFCRPDHPVVQVAYPDAV
AYATWAGRRLPTEAEWEYAARGGPKGGVGFLYAWGDEVCPDGQLMANTWQGKFPYR
NDGALGWKGTSPVGTFPPNRLGLVDMIGNVWEWTATKFSAHHRPGDESHVTCCPPPSG
GDPGVNQVLKGGSHLCAPEYCHRYRPAARSPQSQDSSTTHIGFRCVVS 
 
Homo sapiens LAHSKMVPIPAGVFTMGTDDPQIKQDGEAPARRVTIDAFYMDAYEVSNTEFEKFVNSTGY
LTEAEKFGDSFVFEGMLSEQVKTNIQQAVAAAPWWLPVKGANWRHPEGPDSTILHRPD
HPVLHVSWNDAVAYCTWAGKRLPTEAEWEYSCRGGLHNRLFPWGNKLQPKGQHYANI
WQGEFPVTNTGEDGFQGTAPVDAFPPNGYGLYNIVGNAWEWTSDWWTVHHSVEETL
NPKGPPSGKDRVKKGGSYMCHRSYCYRYRCAARSQNTPDSSASNLGFRCAADRLP 
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5. Copper Binding in Formylglycine Generating Enzyme 
GE has previously been identified as a cofactor-free oxidase. This classification raised 
significant interest in FGE research and was primarily based on the absence of cofactors or 
metals in protein preperations and existing crystal structures. Additionally, no distinct metal 
recognition sites had been identified. With the identification of copper as a crucial electron donor 
in FGE catalysis, the identification of the metal binding site is an important target. Many copper 
containing proteins and enzymes use thiolates or thiol ethers to coordinate metals in active or 
binding sites. Notable examples such as Atx1 have been discussed earlier (see also section 2.2). 
Similarly, the FGE active site contains two highly conserved cysteine residues which are believed 
to be involved in disulfide formation with the substrate.[56] The previous chapter showed the 
requirement of a 1:1 ratio of copper to enzyme, suggesting formation of a protein : metal 
complex.   
In the following chapter we show the particitpation of the two conserved cysteine residues in 
metal binding. Since only reduced thiols efficiently bind copper, we hypothesize that the disulfide 
between FGE and the substrate, which is observed in crystal structures, is an artefact of the 
experimental conditions and that the substrate coordinates to copper via its cysteine residue. 
Additionally, copper remains in the active site over the course of multiple turnover. From these 
findings we propose that FGE should be categorized as a copper-dependent oxidase.  
 
5.1  Identification of metal binding site in FGE from T. curvata  
The effect of copper on FGE reactivity is significant. However, none of the crystal structures 
published to date show a transition metal present in the protein structure. Many metal 
containing proteins can be isolated in the metal bound form and in a subsequent step require 
removal of the metal to yield the apo-protein. While the copper content of the respective culture 
medium could be a limiting factor, other metal containing proteins have been isolated under 
similar conditions (human cancer cell line or E.Coli). The absence of copper from FGE 
preperations requires alternative explanations. One possible reason is the failure of the protein 
to efficiently bind copper. To test this hypothesis we adopted a previously published method to 
determine copper(I) binding affinities.[100] This assay relies on the equilibrium between a colored 
complex of copper(I) and bathocuproinedisulfonic acid (BCS) and the protein (or other ligand) of 
interest. We found, that recombinantly produced FGE does not bind copper significantly stronger 
than bovine serum albumin (BSA) and far less strongly than DTT, which is always present in the 
reaction mixture (see Fig. 5-1, left). It has been reported that for the copper binding protein Atx1, 
the oxidized structure containing a disulfide bond in the active site, is absent of metal ions and is 
therefore not biologically relevant.[101] Knowing that FGE from T. curvata contains a disulfide 
bond in the active site upon isolation from the host organism (see chapter 4.1), we propose, that 
only reduced FGE is able to bind copper. This might explain the lack of metal ions in published 
crystal structures since FGE requires to be actively reduced in order to bind copper.   
Indeed, after reduction of FGE4C with DTT, the affinity for copper(I) increases significantly  
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Fig. 5-1: Copper binding of different ligands in competition with bathocuproinedisulfonic acid (BCS). Left: FGE in its 
resting state does not bind copper stronger than a random control protein with no known copper affinity (BSA) and far 
less strongly than DTT, which is known to be a strong copper(I) ligand. Right: Direct comparison of reduced and 
oxidized FGE4C as a ligand of copper(I). 
  
(see Fig. 5-1, middle) with dissociation constants comparable to other copper(I) binding proteins 
(KD,WT = 10
-17.1 M; KD,4C = 10
-17.1 M; KD,Atx1 = 10
-17.4 M[100]). Importantly, the copper affinities of FGEWT 
and FGE4C appear to be very similar, leading us to conclude, that none of the cysteine residues 
outside the active site contribute to copper binding. To support this notion about the location of 
copper binding and the crucial role of the cysteine residues in this, we analyzed additional two 
variants of FGE that lack either of the two active site cysteines (FGEC269S and FGEC274S see Tab. 
5-1). To ensure a completely reduced state of cysteines withing the enzyme we performed the 
BCS in the presence of 2 cysteamine as a reducing agent. This small molecular weight thiol does 
not interfere with the assay up to concentration of 2 mM but readily reduces the enzyme (see 
appendix Fig. 5-9). In agreement with previous reports, FGEC269S and FGEC274S show little catalytic 
activity, with regards to the wild type enzyme (see Tab. 5-1).[48] Additionally, they do not show 
any sign of competition for Cu(I) during the coppper affinity assay (see also Appendix Fig. 5-8) 
supporting the hypothesis that copper binding is only achieved under participation of both 
cysteine residues in the active site. 
DTT has an affinity two orders of magnitude below that of FGEWT and FGE4C (see also Tab. 5-1). 
Under our in vitro reaction conditions, however, the concentration of reducing agent is three 
orders of magnitude above that of FGE (cFGE = 2 µM vs. cDTT = 2 mM). The rational  
 
Tab. 5-1: Copper(I) binding affinities of different FGE variants and DTT determined by using a UV based competition 
assay with BCS. The respective reaction rates and the rates of copper release for selected mutants are shown.  
Ligand pKD kreact [min
-1
] koff,Cu [min
-1
] 
FGEWT 17.1 0.42 - 
FGE4C 17.1 1.3 - 
FGEC269S n.a. 0.3 ∙ 10
-3 - 
FGEC274S n.a. 0.01 ∙ 10
-3 - 
FGES266A 17.7 6.3 ∙ 10
-3 0.06 
FGES290K 16.3 1.2 ∙ 10
-3 - 
FGEW108A,W109A 16.2 0.3 ∙ 10
-3 0.09 
DTT 15.1 - - 
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behind the competition of FGE for copper in such a buffer remains unclear. One explanation 
might be an increased affinity for FGE under the reaction conditions. We therefore analyzed the 
copper binding affinities of the substrate-enzyme complex. The cysteine containing peptide 
however, is a strong copper binder itself (see Appendix Fig. 5-10) this renders saturating 
concentrations of the substrate incompatible with the BCS assay. To circumvent this issue, we 
synthesized a peptide with a serine instead of the substrate cysteine (peptide sequence: 
Abz-SALSSPTRA-NH2). Investigations of the copper binding affinity in the presence of this serine 
containing substrate did yield similar affinities as the substrate free samples (KD,4C = 10
-17.1 M vs. 
KD,4C+Peptide = 10
-17.4 M, see also Fig. 5-1, right). However, the serine containing peptide was also 
shown to have only weak interactions with FGE4C in an inhibition assay (see Appendix Fig. 5-10) 
which questions the viability of this enzyme-substrate complex. 
To further advance our understanding of copper binding, we generated additional inactive 
mutants. The variants FGES266A, FGES290K and FGEW108A,W109A prove to be many fold less active than 
FGEWT but still show high copper affinities (see Tab. 5-1). Trp126 and Trp127 aswell as Ser266 
(green in Fig. 5-2) are located in close vicinity to the active site cysteines (yellow in Fig. 5-2, d < 14 
Å), whereas Ser290 (red in Fig. 5-2) is positioned at the very end of the substrate binding cavity 
 
 
   
   
Fig. 5-2: Capability of different inactive FGE mutants to compete for copper(I) in direct comparison with FGE4C. Top: 
Surface representation of the substrate binding groove of FGEhuman (PDB 1Y1E
[56]) with locations of the introduced 
mutations. Yellow: Active site cysteines Cys269 and Cys274; Green: Trp126, Trp127 and Ser266. Red: Ser290. Bottom: 
Product production of FGE4C in the presence of a second protein. Only FGE variants that do contain the active site 
cysteines and bind the substrate can efficiently compete for Cu(I). 
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(distance to Cys269 = 18 Å). We introduced this specific 
hydrogen bonding interactions with the substrate and to thereby generate a FGE variant 
does not produce the product 
hydrogen bonding interaction, the protonated lysine residue 
and thereby generate repulsive interactions
This would then further weaken
shows a catalytical efficiency that is 440
(kcat/KM,S290K = 6.6 ± 0.2 M
-1min-1 
mutation being positioned far away from the reactive centre of FGE (see also 
Tab. 5-1). In contrast, the mutated trytophane residues are in close vicinity to the active site and 
substitution of these with alanine residues most likely strikes a hole into the structure, which 
then significantly disturbs the active site architecture. In agreement with these remarks, the 
resulting protein variant has a catalytic efficiency far below that of the wild type enzyme 
(kcat/KM,W108A,W109A = 1.7 ± 0.3 M
-1
saturated with substrate, indicating some loss of protein
serine to alanine mutation, in contrast
positioned to undergo van der waals 
likely contributing to the charge composition of the active site. Removal of these interactions 
could consequently interfere with local charge distributions and thereby 
of other nearby active site residues (i.e. Cys269 or Cys274), rendering FGE
activity than FGEWT (kcat/KM,S266A =
The metal binding capability of 
the active mutants FGEWT and FGE
the pKa of cysteine residues has been evaluated previously for the copper 
might provide an explanation for the decreased 
Cys269 or Cys274.[102]   
With the copper binding in the active site of FGE 
acts as in complex with the enzyme and hence can be categorized as a cofactor or whether the 
metal is released after each turnover and is then reduced in
enzyme (see Scheme 5-1). One way to test 
copper ions from solution and hence make them unavailable for FGE as soon as the metal leaves 
 
Fig. 5-3: Crystal structure of FGEhuman 
inactivating mutations S266A and S290K (numbering based on FGE
the chloride ion (green sphere, dSer266-C
provides hydrogen bonding to the argininge residue of the substrate (d
nitrogen of arginine). 
mutation with the intent
yet still contains an intact active site. In add
would introduce a positive charge 
 with the positivly charged arginine of the substrate
 substrate binding. By doing so we generated a mutant that 
-fold lower than that of the wild type 
vs. kcat/KM,WT = 2900 ± 50 M
-1min-1) despite the introduce
min-1 vs. kcat/KM,WT = 2900 ± 50 M
-1min-1). However, it cannot be 
-peptide interactions. The 
, is more subtle. The serine residue appears perfectly 
interactions with a nearby chloride ion (see 
also influence 
S266A
 49 ± 8 M-1min-1 vs. kcat/KM,WT = 2900 ± 50 M
-1min
the inactive mutant FGEW108A,W109A is only slightly lower than for 
4C (see Tab. 5-1). The effect of second-coordination residues on 
chaperon Atx1 and 
affinities of the variants with mutations close to
being shown, the question arises, whether Cu(I) 
 solution rather than bound to the 
this is to provide a ligand that can efficiently remove
 
with disulfide bound substrate (PDB 2AIK[56], 1.73 Å) showing the location of 
WT). Ser266 is located in van der waals dist
l = 3 Å). Ser290 is located at the end of the substrate binding groove, where it 
Ser290-Arg = 3 Å, side chain oxygen of serine to 
 to destroy 
that 
ition to the lost 
. 
d 
Fig. 5-2, left and 
effect of the 
Fig. 5-3), most 
the pKa’s 
 60-fold lower in 
-1).   
 
 
 
ance to 
η-
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Scheme 5-1: Possible pathways for copper binding and unbinding. Copper(I) can either remain in the active site as an 
integral part of the enzyme, which then does not allow for an external ligand to remove the metal and hence making it 
unavailable for FGE. Secondly, if copper is released into the solution after each turnover, external copper binder should 
be able to bind copper and consequently reduce the effective copper concentration available for FGE. 
 
the enzyme complex. To our mind the most suitable ligand with a similar affinity for copper(I) is 
FGE itself. We prepared an active Cu:FGE4C complex by incubating the enzyme with substrate and 
reducing agent in the presence of copper. One minute after initiation, the reaction was 
additionally supplemented with 10 molar equivalents of inactive mutants (with regards to FGE4C) 
and the change in product concentration was monitored (see Fig. 5-2). Control experiments with 
BSA, FGEC269S or FGEC274S, did not influence the reaction rate of the Cu:FGE4C, which supports the 
previous data from the BCS copper(I) competition assay. Interestingly, only FGES266A and 
FGEW108A,W109A show an inhibitory effect, with the final rate after equilibration of the system being 
at least 15 fold lower than the initial rate in the absence of competing ligand. This is in good 
agreement with the copper being redistributed between 0.5 µM FGE4C and 4.5 µM of either 
FGES266A or FGEW108A,W109A. The third variant, FGES290K, does not influence the reaction rate. 
Suprisingly, if only incubated with BCS and Cu(I) FGES290K shows copper binding affinities 
comparable to that of other mutants and only 1-fold lower than wild type. Despite this 
observation, the mutant shows no copper binding affinity in direct competition with FGE4C under 
turnover conditions. We hereby conclude, that the copper binding affinity is enhanced in the 
present of substrate, since only substrate binding should be purturbed in FGES290K.    
When looking at the removal of copper from FGE, the rate at which the product concentration 
levels off in the presence of FGES266A and FGEW108A,W109A is of particular interest. A combination of 
an exponential and linear fit (see Eq. (3)) gives the rates at which copper leaves the active site of 
FGE4C as koff, Cu(I) (see also Tab. 5-1). When supplying the reaction mixture with inactive mutants, 
copper is removed at a rate of 0.06 and 0.09 min-1 with FGES266A and FGEW108A,W109A, respectively. 
This rate is 10 fold lower than the reaction rate of Cu : FGE4C in the absence of competing ligand 
(v4C = 0.82 ± 0.10 min
-1), giving reasons to conclude that copper leaves the active site of the active 
enzyme every 10th turnover. This observation is a clear indication that copper release and 
subsequent re-binding cannot be part of the catalytic cycle and that FGE can hence be 
categorized as a copper-containing oxidase.  
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For catalysis to occur in copper containing oxidases, the oxidation state of the metal is vital. 
Many proteins use single or multiple copper atoms as the active centre. Numerous examples 
exist of such oxidoreductases that keep the metal in a +1 or +2 oxidation state.[31][104] We 
previously established an optimal copper to protein ratio of 1:1 to reach maximal reaction rates, 
indicating a mononuclear copper center (see chapter 4.1). What remains to be untangled is the 
oxidation state of the metal centre. Typically, enzyme redox centres are determined by electron 
paramagnetic resonance (EPR), a method for the detection of unpaired electrons.[105] While metal 
centres with only paired electrons such as Fe(II) or Cu(I) do not show EPR signals, other oxidation 
states generate distinct signals that can be interpretated. Careful evaluation of these patterns 
may provide information about the type of radical or the environment.  
In the case of FGE, our intention was to determine the redox state of the copper atom. Upon 
incubation of FGE with substrate in the presence and absence of copper and DTT we observed 
different EPR spectra after freeze quenching the reaction (see Fig. 5-4). FGE catalysis is slow in 
the absence of metal and DTT (see also chapter 4.1). With no metals being present and no 
turnover occuring, FGE consequently appears EPR silent. We interpret this as the absence of free 
radicals or unpaired electrons. Upon addition of CuSO4 to the reaction mixture, the EPR spectrum 
shows a strong signal for copper(II). Due to the absence of reducing agents the metal remains in 
its +2-oxidation state. The enzyme, likewise, remains in its oxidized state with a disulfide bond 
present in the active site and is unable to bind copper (see also page 42). Under turnover 
conditions, i.e. in the presence of copper and DTT, the reducing agent generates the free thiols in 
the active site as well as Cu(I), which FGE will then tightly bind. Addition of substrate initiates the 
reaction, during which the metal remains in the oxidation state +1. The absence of any EPR signal 
during catalysis can be interpreted as the absence of Cu(II) (or Cu(0)). However, a +2 species  
 
 
 
 
Fig. 5-4: Top: Electron configuration of copper in  the ground state and in the first and second oxidative state.  Bottom: 
X-band (~9.52 GHz) continuous-wave EPR spectra of 50 µM FGE in the presence of 500 µM substrate, 0 – 50 µM copper 
and 0 – 5 mM DTT at TEPR = 150 K. Only samples containing copper(II) without addition of reducing agent show an EPR 
signal, whereas reaction mixtures that have been supplied with copper and DTT show the metal as being EPR silent (i.e. 
Cu+). Zoom of the region with strongest Cu(II) signal component (left) and full spectrum of the Cu(II) species (right). 
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could be short living, hence low in concentration which would render the intermediate invisible 
with this method.  
Knowing that FGE contains 3d10 4s0 copper allows us to search for other metals that could adopt 
such a configuration. These metals could then possibly replace copper in the active site. Other 
Cu(I) binding proteins such as metallochaperons Atx1 and P-type ATPases have been shown to 
bind Cd, Hg, and Ag as well. Silver, in particular, has been a well studied example of a replacing 
metal for copper proteins.[106] Our previous investigations have shown that none of the three 
metals are capable of supporting FGE catalysis (see chapter 4.1), which can be explained by their 
different redox potential (E0Cu = 0.35 V vs. E
0
Ag = 0.80 V). However, binding of the metal might still 
be possible. Our interest was therefore to investigate the possible replacement of active site 
copper by silver ions. Similarily to the perviously shown removal of copper by inactive FGE 
mutants, we then went on to analyze copper replacement by silver. The reaction rate in the 
presence of silver being significantly lower than with copper (kAg/kCu ≈ 0.1, see also Fig. 4-5 
section 4.1.3) one can again simply monitor the product formation. If silver would be capable of 
replacing copper from the active site, the following inactive Ag:FGE complex should lead to a 
lower rate of product formation. Indeed, when doing so, one can clearly observe a reduced rate 
of product release upon the addition of silver(I) (see Fig. 5-5). Reaching the half maximal rate at 
0.5 equivalents of AgNO3, the binding of newly introduced metal appears to be similarly strong as 
the copper binding. Calculations have been performed by others to determine the binding 
energies of copper and silver in complex with free hydrogen sulfide.[107] These studies show a 
decreasing binding energy for the series Au > Cu > Ag. However, other ligands from the the active 
site surroundings might additionally influence the metal binding energies of copper and silver. 
Upon addition of one equivalent of Ag+ to the reaction mixture the rate of product formation is 
decreased to 30 % of the initial rate in the absence of silver (only copper), indicating a stronger 
binding of silver. Following our previous experiments to determine copper off rates from FGE4C 
(see Fig. 5-2) similar efforts were made to confirm the earlier data (see Fig. 5-5). Upon the 
addition of 10 equivalents of AgNO3 to an ongoing reaction with FGE4C in the presence of Cu(I) 
the rate of product formation drops within 30 – 60 mins to a value even below the rate of FGE4C 
in the absence of copper (k-Cu = 0.35 min
-1, k+Ag, t = 45 min = 0.07 min
-1). Along with our previous 
hypothesis, that the inherent activity of FGE is attributed to residual, copurified copper, we 
believe, that silver also competes with the residual coppper in the enzyme sample and is thereby 
capable of lowering the reaction rate even below that of native FGE. Again, the rate at which the 
product formation is slowed down describes the rate at which copper leaves the active site of 
FGE. In good agreement with the previous results the copper off rate in the presence of silver 
was determined to be kCu, off = 0.14 min
-1 (see also in the presence of inactive mutants: 
kCu, off = 0.06 - 0.09 min
-1).   
From the displayed data it is not clear, whether the reduced reaction rate is indeed derived from 
a replacement of copper from the active site. Inactivation of FGE by other pathways is likewise 
possible. As elevated concentrations of metal ions in protein solutions can cause agregation and 
inactivation of enzymes, we analyzed the resistance of the FGE : Ag complex to thermal stress. 
The point of thermal transition of FGEWT in the presence of one equivalent of silver nitrate is 
similarly increased as described previously for copper(I) (see Fig. 5-6 and chapter 4.1). Likewise, a 
three state transition is observed with part of the structure denaturing at 60 °C, whereas global 
unfolding is only achieved at temperatures above 80 °C. The extend of the low-temperature  
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Fig. 5-5: Top: Silver replaces the active site bound copper ion. Bottom: Rate of product formation of FGE4C in the 
presence of copper and silver. Left: Reaction mixtures containing a FGE:Cu mixture at a ratio of 1:1 were supplied with 
increasing amounts of AgNO3 up to a Cu:Ag ratio of 1:10. Increased concentrations of silver lead to decreased reaction 
rates. Right: Time dependency of silver inhibition. Silver was added one minute after initiating the reaction. The off 
rate of copper from the active complex was determined as described above (see also Equation 3) to be 
koff,Cu = 0.14 min
-1. 
unfolding, however, appears to be greater than previously observed for copper containing FGE. 
The comparable shift of the overall protein stabilization, however, suggests an analogous binding 
mode. It favours the hypothesis that silver moves into the copper binding site, where it replaces 
copper. Silver does therefore not inactivate the protein by unspecific interactions, such as 
oxidation or aggregation. Additionally, this observation suggests that the copper induced rate 
enhancement is decoupled from reorganization and stabilization of the tertiary structure. 
Stabilization of the overall structure is achieved even for inactive metal:FGE complexes. The 
increased reaction rate of the Cu:FGE complex is likewise not a result of the structural change.  
 
 
Fig. 5-6: Change in CD signal of FGEWT at λCD = 222 nm at increasing temperature in the presence of silver nitrate. Silver 
ions induce a similar protein stability as observed for copper(I). 
 
  
  
 
5.2 Conclusion 
The presented data identifies FGE as a copper
occurs at rates of kreact = 0.7
kCu,off = 0.06 – 0.1 min
-1. Copper binds tightly
the active site, with a KD,WT =
such as copper chaperon Atx1 or the copper transporting ATPase WLN5
KD,WLN5-6 = 10
-17.6 M both at pH
residue show no detectable affinity for Cu(I). Previously, these residues were thought to be 
involved in substrate binding through an intermolecular disulfide bond of the enzyme and the 
substrate.[56] In light of the presented affinities, together with the importance of copper for 
catalysis, we postulate that mutants lacking either of the two cysteine residues in the active site 
show inability to perform turnover due to insufficient cop
comparable copper affinities, but fails to compete for copper if other FGE variants such as FGE
are present, indicating the participation of the substrate cysteine in the comp
crystal structure of FGEhuman
mutated Ser269 (cysteine in the 
protonated oxygen (pKa ~ 15)
(pKa ~ 7-8) and favour metal binding. 
stabilize copper binding with a free coordination position on top to accomodate a potential 
oxygen molecule (water in the s
binding, we hypothesized, that copper will be bound at this position.
however fail to illustrate this dependency. The enzyme
after introduction of a Cys ->
the active site cysteines is crutial for copper binding t
and substrate most likely renders the complex unable to bind copper. 
Furthermore, the low affinity of oxidized FGE for copper ions might provide rational for the 
absence of bound metal in any of the crystal structures publihsed to date. Keeping FGE in a 
reducing environment during the crystalization 
this issue when co-crystallizing the 
be a second route for successful crystalization of a metal bound FGE. The intro
different metal with the resulting loss in activity but remaining structural features (i.e. increased 
  
Fig. 5-7: Possible copper-binding site in FGE. Active site of FGE
curvata) with a co-crystallized chloride ion (green sphere) 
as water.  
-dependent oxidase. While product formation 
 – 1 min-1 the rate of copper release has been determined to be 
 to the two cysteine residues previously identified 
 10-17.2 M, which is comparable to other copper(I) containing proteins 
 7).[100] Mutants lacking either of the two highly conserved cysteine 
per binding. The mutant FGE
 (see Fig. 5-7) shows a chloride ion coordinated by Cys274 and the 
original structure). The introduced serine residue contains a 
, while the original cysteine would rather be deprotonated
The substrate cysteine is neatly positioned to further 
tructure). While Ser266 appears to be less crutial for copper 
 Current crystal structures 
-substrate complex 
 Ser mutation in the active site.[56] As the reduced oxidation state of 
he presence of a disulfide 
  
experiments might be one route to circumvent 
FGE with copper. Replacement of copper by 
 
human (PDB 2AIK, numberin
coordinated by three catalytically important residues as well 
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thermal stability) further supports the participation of copper in redox chemistry. EPR 
spectroscopy showed an EPR-silent copper species, which suggests that copper(I) is the active 
metal in the active site. However, if copper is involved in redox chemistry, one would expect a +2 
species to be present as well. Short living species that do not reach considerable concentrations 
during the ongoing reactions and therefore remain below detection limits as well as the 
generation of EPR silent cupric oxygen species have to be concidered though.[108][109] Head-on 
oxygen binding was observed in synthetic Cu(II) complexes that do lack any EPR signal, which was 
attributed to the presence of a triplet state.    
With copper only being released at a rate of koff,Cu = 0.06 – 0.1 min
-1 and reaction rates of 
kreact = 0.5 – 1.0 min
-1 FGE should be categorized as a copper-dependent oxidase.   
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5.3 Experimental 
Plasmid Construction. Mutations were introduced by site directed mutagenesis using the vector 
pET28-FGEWT as a template. Synthetic primers were ordered from Mycrosynth and are shown in 
Tab. 5-2. After PCR, the fragments, as well as the pET28 target vector were treated with NdeI and 
XhoI restriction enzymes, followed by ligation of the gene into the target vector by T4 DNA ligase. 
The identity of final plasmids was confirmed by sequencing analysis (Microsynth). 
Tab. 5-2: Primer sequences used for the mutation of the FGE variants described in this chapter. 
FGE variant Primer 3’  5’  
 Sense Antisense 
FGES266A 
AAGGGCGGCGCTTTCCTGTGCCACGA
GT  
GGCACAGGAAAGCGCCGCCCTTGGT
GAC  
FGES290K CCGACTCCAAAGCCGCCCA TGGGCGGCTTTGGAGTCGG 
FGEW108A,W109A GCGCCCGCGGCGGTGGCG CGCCACCGCCGCGGGCGC 
FGEC269S GTTCCTGTCCCACGAGTC GACTCGTGGGACAGGAAC 
FGEC274S AGTCGTACTCCAACCGCTA TAGCGGTTGGAGTACGACT 
 
 
Protein Expression and Purification. FGE mutants were produced as previously described (see 
chapter 4.3). Genes were transfered into BL-21 pLys E. coli cells. Precultures were inocculated 
with a single colony and incubated at Tinc = 37 °C overnight. Expression cultures of 1 L LB medium 
supplemented with kanamycin and chloramphenicol (50 mg/L and 34 mg/L, respectively) were 
inocculated with 1 mL of preculture. At OD = 0.6 – 0.8 cultures were induced by the addition of 
IPTG. After an additional 3 hrs of incubation at Texpress = 37 °C the cells were harvested by 
centrifugation. The protein was then isolated by Ni2+- affinity chromatography and dialysed into 
NaCl supplemented Tris buffer pH 8 before storage at Tstore = -80 °C. 
 
Tab. 5-3: Calculated and observed molecular weights of proteins described in chapter 5 with comments on the mass 
difference. 
Protein MWcalc [Da] MWobs [Da] Comment 
FGES266A 35292.1 35290.4 Disulfide bond 
FGES290K 35363.2 35360.4 Disulfide bond 
FGEW108A,W109A 35077.8 35075.9 Disulfide bond 
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Analysis of reaction rates. FGE reaction rates were determined as described previously (see 
chapter 4.3).  
 
Peptide synthesis.Peptides were synthesized by Fmoc solid phase peptide synthesis as described 
above (see chapter 4.3). The identity of the peptide was confirmed by ESI-MS (sequence: 
Abz-SALSSPTRA-NH2; MWcalc = 1006.5 Da, [M+H]
+
obs = 1007.5 Da, [M+2H]
2+
obs = 504.2 Da). 
Copper(I) affinity determination. Protein samples were diluted in a 50 mM Tris buffer pH 8 
containing 20 µM CuSO4, 200 µM bathocuproine disulfonic acid (BCS), 2 mM cysteamine and 
4 mM Na2S2O4. The reaction mixture was vortexed and the absorbance at λBCS = 483 nm was 
determined on a Cary 300 Bio UV/vis spectrophotometer. The concentration of free Cu : BCS2 was 
calculated using the molar extinction coefficient of BCS εBCS = 13000 M
-1cm-1. The equilibrium is 
described by Eq. 4[100] which can be linearized to Eq. 5. The slope of the plot yields the KD value by 
using β2 = 10.
19.8 M-2.[100] For measurements using reduced FGE, the protein was incubated with 
5 mM DTT on ice for Tinc = 20 min prior to removal of excess DTT by size exclusion 
chromatography. Oxidized FGE was prepared by treatment with H2O2 prior to removal of excess 
oxidant by size exclusion chromatography. The oxidation state was confirmed by labeling with 2-
iodoacetic acid and analysis by HRMS.  
 ()*+ =
,-.-/0
1, 
2-.-/012	 +
	
34	
  (4) 
 
KD: dissociation constant, β2: formation constant of CuBCS2, [P]total: total concentration of protein, 
[L]total: total concentration of BCS, [MP]: concentration of protein bound metal, [ML2]: 
concentration of ligand bound metal 
 [4]-.-/0[34	] − 2
+
[67+][6]8 − [67+]% = 9:;	 []<<=> − [6]8 − [67+]%% (5) 
with  = [4]-.-/0[34	] − 2
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Labeling with 2-iodo acetamide. FGE was diluted to a final concentration of cFGE = 45 µM in a 
reaction mixture containing 5 mM cysteamine, 50 mM NaCl and 50 mM Tris-HCl pH 8. The 
reaction was incubated at RT for 30 min. Subsequently, 10 mM IAA was added and incubated for 
60 min on ice. Protein modification was subsequently analyzed by LC/HRMS. 
Determination of Cu(I) off rate. Analysis of metal release from the active site of active FGE was 
performed by diluting FGE4C to a final concentration of cFGE = 0.5 µM in a 50 mM Tris buffer pH 8 
containing 0.5 µM CuSO4, 200 µM substrate, 2 mM DTT, 50 mM EDTA and 50 mM NaCl. Reactions 
were initiated by addition of enzyme as the last step. After one minute of incubation the 
competing ligand was added to a final concentration of ccompetitor = 5 µM. Product concentration 
was determined as described previously (see chapter 4.3). The resulting plot was fitted to Eq. 3, 
from which the rate of equilibration has been extracted as koff,Cu. 
   = 	 ∙ (1 − (  ,"#($) ∙ &)) + ' ∙ & (3) 
EPR measurements.  For analysis of the copper oxidation state, samples of FGE4C were diluted to 
a final concentration of cFGE = 50 µM in a 50 mM Tris buffer pH 8 containing 500 µM substrate, 
0 - 50 µM CuSO4, 0 – 5 mM DTT, 50 mM EDTA and 50 mM NaCl. Reactions in the presence of DTT 
were freeze quenched after tinc = 1 min, whereas samples without reducing agent were incubated 
for tinc = 15 min prio to freeze quenching in liquid N2. Temperature: 150 K, modulation amplitude: 
1 mT,microwave attenuation: 15 dB (6.346 mW power), 160 scans each. Spectra were acquired 
on a Bruker Elexsys 500 spectrometer equipped with a super-high Q resonator. 
Analysis of thermal unfolding by circular dichroism. FGE was diluted to a final concentration of 
cFGE = 10 µM in a buffer containing 0 – 10 µM AgNO3, 50 mM Tris, 50 mM NaCl and 2 mM DTT. 
Thermal unfolding was monitored at λCD = 222 nm in a quartz cuvette of 1 mm pathlength while 
heating at 1 °C/min in steps of 1 °C.  
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5.4 Appendix 
 
 
Fig. 5-8: Concentration of CuBCS2 in the presence of increasing amounts of different FGE variants. The absorbance of 
the complex was assayed at λ = 483 nm under the following condition: [CuSO4] = 20 µM, [BCS] = 200 µM, 
[cysteamine] = 2 mM, [FGE] = 0 – 30 µM.  
  
Fig. 5-9: Left: HRMS spectrum of FGE4C after labeling with 2-iodoacetamide. Native FGE does not react with IAA (a), 
wheras FGE4C treated with 5 mM cysteamine is readily alkylated (b, MWcalc,4C,IAA = 35309.5 Da; MWobs = 35308.9 Da). 
Right: Determination of DTT binding affinity in the absence of cysteamine (i) and in the presence of 2 mM cysteamine 
(ii). Cysteamine does not significantly interfere with the assay (pKD, DTT = 15.2; pKD, DTT+cysteamine = 15.9) 
  
Fig. 5-10: Left: Concentration of CuBCS2 in the presence of increasing amounts of cysteine containing substrate 
peptide. The absorbance of the complex was assased at λ = 483 nm under the following condition: [CuSO4] = 20 µM, 
[BCS] = 50 µM,  [peptide] = 0 – 30 µM. Right: Reaction rate of FGE4C in the presence of increasing amounts of serine 
containig peptide (FGE-7). FGE4C was diluted to a final concentration of cFGE = 2 µM in a reaction mixture containing 
200 µM substrate (Abz-SALSCPTRA-NH2), 0 – 2000 µM serine peptide (FGE-7; Abz-SALSSPTRA-NH2), 2 µM CuSO4, 
50 mM EDTA, 50 mM NaCl and 50 mM Tris pH 8.0. After various time points the reaction has been quenched for 
product analysis by addition of 1 volume equivalent of 1 % TFA in 4 M urea. Product formation has been analyzed by 
RP-HPLC. 
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Fig.5-11: Left: SDS-PAGE picture of collected fractions of FGES266A. Middle: SDS-PAGE picture of collected fractions of 
FGEW108A,W109A. A: Pellet; B: Flow through; C: wash with 10 mM imidazole; D: wash with 20 mM imidazole; E: Eluted 
Protein sample; F: MWM. Right: SDS-PAGE pictures of different FGE variants. A: Molecular weight marker; B: 
FGEsmegmatis; C: FGEC269S; D: FGES290K. 
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6. Identification of Reducing Agents for FGE 
he FGE catalyzed reaction from a thiol to fGly is a 2-electron reaction with oxygen being the 
terminal electron acceptor. It has been suggested in the literature that oxygen is fully reduced 
to two molecules of water.[65] To reduce O2 to H2O, however it requires four electrons. While 
during catalysis in FGE the substrate is oxidized by two electrons it requires an additional electron 
donor to fully reduce oxygen..   
We and others have established that the FGE activity depends on thiol-containing reducing 
agents. In vitro reactions are therefore typically supplemented with DTT, mainly due to its low 
redox potential (E’0 = -0.32 V
[117]). DTT however is an artificial compound and is not found in 
nature. The question remains, what is the reducing agent of FGE in vivo? While others have 
reported FGE catalysis in the presence of GSH, we did observe low reaction rates in the presence 
of glutathione (see also chapter 4.1) and therefore suggest that FGE requires a different electron 
donor in vivo.   
In the following chapter we show that FGE performs a single turnover in the absence of an 
efficient reducing agent. The active site cysteines are then reversibly oxidized via a two electron 
oxidation. The resulting modification is equivalent to a disulfide bond in terms of oxidation 
equivalents but cannot be identical since copper binding is still possible. Furthermore, we provide 
evidence that an N-terminal fragment containing a CxC-motif is a prefered redox partner and 
efficiently reduces the enzyme during turnover. 
 
6.1 FGE reduction in vitro 
6.1.1  FGE activity in the absence of reducing agent 
FGE catalysis requires a reducing agent for multiple turnovers to occur. To gain knowledge on the 
redox state of FGE before reduction we performed the reaction in the absence of reducing 
agents. To simplify the setup we chose to initially perform the reaction in absence of copper. 
Without reducing agent the product formation is slowed down within a few hours and reaches a 
plateau (see Fig. 6-1 and Ref. [65]). Addition of DTT after equilibration recovers the initial activity 
as describe above (see chapter 4.1). The plot of the product concentration over time shows a 
burst phase with a steady, linear phase after three hours of incubation. The data is therefore best 
fitted with an exponential fit adjusted by a linear function (see Eq. 7). When using FGE4C the 
amount of product formed in the absence of reducing agent before reaching the linear phase 
matches the enzyme concentration in the reaction mixture (cFGE = 2 μM, cProd,exp = 1.8 μM), which 
is a strong indication for inactivation after a single turnover. Since the substrate peptide contains 
a thiolate, the second linear phase most likely represents the steady state reaction using the 
substrate as a reducing agent at a low reaction rate of ksubstrate = 0.4 ·10
-3 min (vs. kDTT = 0.16 min
-
1). When repeating the reducing agent-free experiment with FGEWT product formation is similarly 
slowed down. The qualitative observation remains the same. Both reactions, with FGE4C and 
FGEWT are slowed down within few hours. FGE4C shows enhanced reactivity during the  
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  = − ∙ exp(−&B=C< ∙ DE=C<) + >DE=B ∙ &B=C< + F (7) 
 [P]exp:  product concentration after the exponential phase  
 kinact: rate of FGE inactivation  
 klinear: reaction rate of FGE reduced by the substrate  
 b: offset of linear phase 
   
Fig. 6-1: Product formation of FGE in the absence and in the presence of reducing agent. Left: If no reducing agent is 
added, FGE4C performs only one turnover (cFGE = 2 μM) after which it reaches it’s oxidized state, waiting for reduction 
to occur.Middle: In the presence of DTT multiple turnover (cFGE = 2 μM) are performed without any sign of inactivation. 
Right: Reducing agent free reaction of FGEWT. The presence of additional cysteine residues appears to favor the 
reduction reaction by internal disulfide shuffeling. 
in vitro assays described earlier (see chapter 4.1). This is also observed in the absence of reducing 
agent. The rate at which FGE4C is inactivated is 2.3-fold higher than that of FGEWT (see also Tab. 
6-1). While the maximal product formation when using FGE4C is equivalent to the enzyme 
concentration, the product concentrations with FGEWT exceed 2 µM (cFGE = 2 µM).  The reason for 
the higher turnover number is most likely the presence of additional cysteine residues on FGEWT. 
These might aid to use the substrate as a reducing agent by providing additional sites of disulfide 
exchange. This might be a slow process which only occurs if no suitable reducing agent is present 
to perform reactivation of the enzyme. The closest cysteine residues in FGEWT can be found 
within a distance of 9 and 13 Å for Cys187 and Cys284, respectively (see Fig. 6-2, estimation 
based on a theoretical structure modeled on the basis of a published structure from FGEhuman 
using swiss model). Since these cysteine residues reside on the surface of FGE, disulfide 
exchanges between FGEs are also to be taken into account. To test for oligomers of FGE we 
assayed the inactivated FGE by SEC. Interestingly, the chromatogramm of FGEWT shows multiple 
peaks corresponding to dimers and multimers, after incubation with excess of substrate (see Fig. 
6-3, left). In contrast the retention volume of FGE4C after turnover is indistinguishable from that 
of unreacted FGE4C (see Fig. 6-3, middle), suggesting that scaffold cysteines are indeed involved in 
disulfide exchange within multiple FGEs. The active site cysteines however are not involved in 
dimerization. To further characterize these isolated FGE intermediates we analyzed the content 
of thiolates as well as the protein mass. After incubation with the substrate in absence of DTT, 
the wild type protein shows less free thiols than the unreacted FGEWT (4.3 ± 0.2 SH/FGE before 
and 2.8 ± 0.1 SH/FGE after turnover). Along with the previous observation that FGEWT 
oligomerizes in absence of DTT we propose that these additional disulfides are formed within 
scaffold cysteines outside of the active site. In  agreement with this hypothesis FGE4C 
  
  
Tab. 6-1: Fitting parameters obtained from fitting the reducing agent independent data to Eq. (
Protein 
FGEWT 
FGE4C 
FGEWT + Cu
FGE4C + Cu
Fig. 6-2: Modelling of structure of FGE
site cysteines Cys269 & Cys274 together with other present cysteines in the vicinity. The closest distance between the 
sulfur atoms of Cys284 and Cys274 is 13
9 Å. Left: Front view. Right: Side view.
  
shows an oxidized redox state before and after turnover (0.3
with this obervation, the mass spectrum of FGE
with only a mass shift of Δ
35195.5 Da, MWobs = 35193.5
shows does catalyze additional product formatio
Fig. 6-9). When DTT is added, though, the reaction proceeds and product is generated over many 
turnover. When repeating the DTT free experiments in presence of copper, the product 
formation is similarly slowed down. Both, FGE
formation, though. While the general scheme is reprod
active cofactor, other pathways occur that complicate the system. One possible 
that copper coordinates free thiols and thereby serves as an electron transporter to assist 
reduction by the substrate. Data evaluation, however, is more difficult
the presence of multiple cysteine 
reaction rate without strong ev
FGEWT reaching the linear phase after 3
The described observations are
active site cysteines as well as within multiple FGE molecules if additional cysteines are present. 
Importantly, even in excess of substrate
observed during LC-MS measurements. Previously, disulfide bond
 
kinact [min
-1
] [P]exp [μM] klinear [μM·min
0.014 3.2 1.7·10-3
0.032 1.8 0.58·10
 n.a. n.a. n.a. 
 0.009 4.7 6.1·10-3
 
WT based on the published structure of FGEhuman (1Y1E). Shown are the two active 
 Å, whereas closest distance between the sulfur atoms of Cys
 
 ± 0.1 SH/FGE after turnover). 
4C is indistinguishable from the unreacted 
MWobs = 2 Da which is reversible by addition of DTT (MW
 Da, and MWobs+DTT = 35195.5 Da). Importantly, the isolated species 
n if incubated with new substrate (see appendix 
WT and FGE4C, show an increased product 
ucible even in the presence of the redox 
 (see Fig. 
residues in FGEWT causes the reaction to proceed
idence for inactivation within 9 hrs (for compar
 – 4 hrs) making fitting to Eq. 7 impossible.
 consistent with the presence of a disulfide bond 
, mixed disulfides of FGE and the 
 formation has
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Fig. 6-3: Left: Size exclusion chromatogram showing FGEWT after DTT independen turnover (b) in comparison to the 
unreacted enzyme (a). Asterisk indicates the elution peak of the reaction product. Middle: Size exclusion 
chromatogram showing FGE4C after DTT independen turnover (b) in comparison to the unreacted enzyme (a). Asterisk 
indicates the elution peak of the reaction product. Right: Product formation of FGE in the absence  of reducing agent 
but in presence of copper. Copper addition facilitates the reduction by the substrate and thereby leads to enhanced 
enhanced product formation compared to the copper free reaction. 
 
in crystal structures with co-crystalyzed substrate. However, during our experiments we do not 
have evidence for such covalent interactions. Heterodimer formation with the active site 
cysteines, as well as to other solvent exposed cysteines throughout the enzyme scaffold, is not 
observed.   
Analysis of the structure of FGE after a single turnover is difficult. Potential instability of the 
oxidized species or presumably short living intermediates and the presence of other thiols such 
as the substrate might conflict with the isolation and identification of the precise modification in 
the active site. We have previously established the presence of a disulfide bond in the active site 
of FGE4C and FGEWT (see section 3.1.2).  Enzymes in the absence of reducing agents will hence 
carry said sulfur-sulfur bond. When incubating FGE (FGE4C-Y273F, for details see chapter 7.2) with 
glutathione, the product formation shows a lag phase with the initial few turnover being slower 
than the later turnover in the second linear phase. This lag phase is not observed with DTT. 
 
                              
 
 
Fig. 6-4: Top: Reaction scheme describing the reduction of the disulfide containing FGEox by GSH and the reactivation 
of FGE*. Bottom: Product formation of FGE4C-Y273F with deuterated (empty circles) and non-deuterated (solid squares) 
substrate using GSH (cGSH = 2 mM) as a reducing agent shows lag phase. The linear phase (black) is fitted with a linear 
curve (dashed lines). The rates of reduction of FGEox have been determined by fitting the data points of the initial 
30 min with [P]=A∙exp(-k∙treact)+y0. 
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The increasing reaction rate during catalysis in presence of GSH indicates that reactivation of the 
inactivated FGE (FGE* in Fig. 6-4) is faster than the initial reduction of the disulfide bond in FGEox 
(k2 > k1). The extent of the lag phase though, is independent of the reaction rate, which is 
observed when using deuterated substrate (β-proton substituted by deuterium). While the 
secondary linear phase shows the expected isotope effect of KIE = 2.9, the rate of reduction of 
FGEox in the lag phase is constant at kred,H = 0.06 min
-1 and kred,D = 0.07 min
-1 (at cGSH = 2 mM) with 
the non-deuterated and the deuterated substrate respectively, indicating that the initial 
reduction is decoupled from the C-H bond breaking reaction. Since the linear phase shows the 
isotope effect, the reactivation reaction (k2) must be faster than the rate limiting step. The 
structure of FGE* and FGEox must thereby be different.  
In summary, FGE cycles through an oxidized intermediate which is not identical to the resting 
state of the enzyme containing a disulfide bond. Additionally the formation of a disulfide bond 
during turnover, would cause release of the metal ion due to the low binding affininty of the 
disulfide-containing FGEox. Unbinding of copper, however, is not observed since the rate of 
copper release from the enzyme was shown to be lower than the rate of product formation (see 
chapter 5). Possible oxidized enzyme intermediates that are capable of metal binding are sulfinic 
and sulfenic acid derivatives of the active site cysteines as found in nitrile hydratases.[111] Sulfinic 
acids however are not readily reduced by thiols at ambient conditions and require complex 
enzymatic systems to be reduced in vivo.[112] Along with previous work of others, we therefore 
suggest the formation of a sulfenic acid in the active site of FGE, even though it has not been 
detected to date.[65] 
6.1.2  Scope of reducing agents compatible with FGE 
Previous reports suggest a stimulation of FGE activity in the presence of low milimolar 
concentrations of glutathione and DTT, with high concentrations of GSH inhibiting fGly 
generation.[3] In order to question the dependence on reducing agents of FGE we performed 
further experiments with a broader range of reducing agents (see Scheme 6-1 and Fig. 6-5, left). 
Others have previously suggested that FGE can catalyze thiol oxidation in the presence of GSH. In 
contrast this, during our in vitro assays, the presence of GSH does not support FGE catalysis 
(insufficient reduction of FGEox, see above). Reactions typically contain EDTA as a chelator for 
excess and undesired metal ions. To test whether trace metals in the reaction buffer could 
facilitate the reaction with GSH we reacted FGE with GSH in absence of the metal chelator. 
Interestingly the GSH-mediated reaction in presence of EDTA is significantly slower than in 
absence of EDTA (see Fig. 6-5, middle). We therefore hypothesize that trace metals in the 
reaction buffer assist the transfer of reduction equivalent from GSH towards FGE. However, there 
is no extensive study investigating this hypothesis to date.   
Only few small molecular weight thiols do support efficient catalysis with FGE. Dithiol containing 
reducing agents like DTT and 2-amino butanedithiole (ABDT) perform just as well as very small 
molecules like cysteamine. In contrast, none of the other tested reductants did enhance the 
reaction rate to that extent.  
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Scheme 6-1: Scope of reducing agents tested for there potential to efficiently support the FGE catalyzed aldehyde 
formation. 
One possible explanation for the different reactivities is the different pKa of the thiol group in 
each of the reducing agents. Comparison of the pKa and the activity of FGE in the presence of the 
respective reductant suggests that there is no correlation between thiol pKa and reactivity. 
Typical reaction mixtures for analysis of formylglycine generation are buffered at pH 8, which 
results in the majority of reductants being protonated (see Tab. 6-2). The fastest product 
formation is obtained for thiols with a pKa range of 8.2 – 9.2, while other thiols like cysteine also 
share similar pKa values but do not accelerate the reaction. One common characteristic of well 
performing thiols is the absence of carboxylic acid groups, suggesting a hindered binding of 
negatively charged reducing agents. Under the assay conditions the acid groups will be negatively 
charged and potentially conflict with negative charge on the protein surface. The active site of 
FGEWT is flanked by several negatively charged residues (namely Glu40, Glu105 & Glu271, see also 
Fig. 6-5, right) which might create a degree of repulsion and hence hinder the movement of the 
reducing agent to the active site. In the human variant these residues are found to be Gln110, 
Ala176 and Arg338, hence either positive or neutral residues. It is therefore not clear 
   
Tab. 6-2: pKa values and redox potentials of thiol groups of different reducing agents together with their relative 
activity using FGE4C. 
Red. Agent pKa of RS-H E’0 [V] Rel. Activity [%] 
DTT 9.2 -0.32[117] 100 
Cysteamine 8.2[113] -0.24[116] 96.6 
MPA 10.3[114] - 22.2 
L-Cys 8.3[113] -0.24[116] 22.2 
D-Cys 8.3[113] -0.24[116] 23.3 
AcCys 9.5[113] - 15.5 
ABDT 8.2[115] -0.32[117] 105.7 
GSH 9.6 -0.25[116] 6.5 
 
  
 
Fig. 6-5: Rate of product formation of FGE
formation of FGE4C in the presence of different reducing agents (see 
or dithiols efficiently perform reducing reactions.
glutathione is dependent on the presence of metal chelators in the reaction mixture.
structure of FGE from T. curvata based on a published structure of FGE from 
glutatamates are highlighte in blue, while histidines, arginines and lysines are highlighted in red. The active site 
cysteines are colored yellow.  
whether a similar dependency will be observed for FGE
efficiency of a wide array of reducing agents was not performed to date.
In conclusion, FGE from T. curvata 
groups or very small reducing agents. Negative charges other than the thiolate decrease the 
reactivity. 
6.1.3  Reducing agent in vivo
The best reducing agents for the 
and ABDT both display a very low redox potential making them extraordinary good reducing 
agents (see Tab. 6-2). These, however, are not available in the cellular context. The question of 
what is the electron source 
thioredoxins or disulfide isomerase
the reduction potential of these thioredoxins 
(E’0,Thx = -0.23 to -0.27 V
[118]) they do share the common feature of the bis
In humans FGE interacts with ERp44 
of FGE (residue 34-68 of the human variant) through disulfi
covalent interactions (see also chapter 
being crucial for retention in the 
for in vitro reactivity.[51] It contains two cysteine residues (Cys50 and Cys52) that are involved in 
binding to ERp44 but also lead to homodimer 
homodimer, however, appears to be labile and is readily reduced to the monomers in the 
presence of a reducing agent. The 
Cys50.[51] Such a CxC motif has been described as a mimic of disulfide isomerases, which utilize a 
CxxC motif to catalyze disulfide shuffeling.
containing the CxC motif, we envision that FGE activity might be restored by the presence of the 
N-terminal domain even if additional reducing agents are absent. 
To test whether this domain can suppor
the core motif of the N-terminal domain from human FGE (see 
motif the sequence of the N
 
   
4C in the presence of different reducing agents. 
Scheme 6-1). Either small molecular weight thiols 
 Middle: Rate of product formation in the presence of DTT and 
 Right:
H. sapiens (PDB 1Y1E). Aspartates and 
human. An extensive analysis of the 
 
shows a preference for reducing agents with two me
 
in vitro reaction contain two thiol grous or are very small. DTT 
in vivo remains. Typical reducing agents in vivo
s. The latter require NADH as a terminal electron donor. 
is lower than that of DTT or ABDT 
-thiol functionality. 
(see also section 2.3.2, p. 13) through the N
de bond formation as well as non
2.3.2).[51] This N-terminal domain has been identified as 
ER and hence for in vivo activity, but appears to be dispensible 
or intramolecular disulfide bond formation.
in vivo activity only depends on the presence of Cys52 but not 
[110] With the N-terminal domain in eukaryotic 
  
t the in vitro reaction, we synthesized a peptide encoding 
Fig. 6-6). In addition to the CxC 
-terminal domain shows a second interesting charac
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Fig. 6-6: Sequence comparison of the N-terminal domain from FGEhuman (residue 34 – 72 of the human FGE gene), the 
two synthetic peptides used for the reducing agent analysis (PepN and PepN*, single letter code ‘B’ for 2-aminobenzoic 
acid) as well as two substrates (substrate 1 used for cocrystalization in Ref [56]; substrate 2 used in this study). 
Cysteine residues are highlighted in green (Cys50 and Cys52 of FGEhuman). Conserved residues, that are portentially 
involved in binding are highlighted in yellow. 
second two cysteines are very close in proximity to an amino acid sequence that is similar to the 
substrate recognition sequence (CxxPxR vs. CxPxR in the substrate). We therefore hypothesize, 
that the N-terminal domain binds to the enzyme via similar interactions as the substrate. To test 
this we additionally synthesized a second peptide with potentially reducing properties (PepN*), 
but with key residues in the recognition motif (Pro, Arg and His) being displaced. With the two 
peptides in hand we assayed FGE4C activity in the presence of either of the two peptides. The 
variant with only two cysteine residues was chosen in order to reduce possible side effects and 
minimize disulfide shuffling of scaffold cysteines. As a terminal electron donor we selected GSH 
and supplemented each reaction additionally with 2 mM GSH to ensure that PepN and PepN* 
would be present in the reduced oxidation state. The reaction rates in the presence of PepN (see 
Fig. 6-7) are comparable to previously observed reaction rates in the presence of DTT or ABDT 
(kDTT = 0.75 min
-1; kPepN = 0.78 min
-1). In the control reaction with PepN* product formation was 
observed at a 3-fold lower rate, which is in agreement with a less efficient binding of the 
scrambled peptide sequence. The presence of GSH however does not effect the reaction rate.   
Despite the long sequence of PepN and PepN*, catalysis under participation of either of the two, 
occurs at significantly higher rates than in the presence of the tripeptide GSH, indicating that size 
is infact not the limiting factor. The presence of a two mercapto-groups in close vicinity to each 
other is most likely more important. The rational design of the two reducing agents suggests a 
disadvantageous binding of the randomized peptide structure. In good agreement with this 
hypothesis the KM value with FGE4C is KM,PepN = 40 µM and KM,PepN* = 70 µM while in the case of 
DTT this was determined to be KM,DTT = 1000 µM (Fig. 6-8, left and middle). The catalytic efficiency 
of FGE4C in the presence of PepN is therefore 25-fold higher than in presence of DTT. With DTT 
being a non-natural reducing agent, in the light of this data, it is more likely to be the case, that 
 
 
Fig. 6-7: Rates of product formation of FGE4C in the presence of PepN and PepN* as a reducing agent. While both 
peptides are capable of reducing FGE only PepN performs to a similar extend as DTT or ABDT. Supplementation with 
GSH does not significantly affect product formation.  
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Scheme 6-2. Reaction scheme of dithiol reduction of oxidized FGE (A) versus reduction by two individual thiols (B). The 
close vicinity of the second thiol in A favours the direct attack and reduces the enzyme. If dependent on two individual 
thiol molecules, the reaction is slowed down by the back reaction of the mixed disulfe to the oxidized FGE and by the 
limitations in diffusion of the second thiol towards the active site. 
FGE requires a peptide type reducing agent. Due to the lack of an extensive investigation of 
reducing peptides of different length and sequence one cannot furhter comment on the ideal 
structure and sequence, though. Importantly, the KIE of FGE is maintained with the peptidyl 
reducing agent (KIEPepN = 3.6, KIEPepN* = 2.7, see Fig. 6-8, right), indicating that the mechanism of 
action is not perturbed. DTT and ABDT exhibit very low reduction potentials, the reduction 
potentials of PepN and PepN* are yet to be determined. In a cellular context, thioredoxin often 
perform reduction reactions. The redox potential of such thioredoxins are typically carefully 
tuned to a value that allows for oxidation by other oxidized substrates, but likewise allows for 
subsequent reduction by a secondary (most often NADH driven) system to regenerate the active 
thioredoxin.[119] A too low reduction potential would thereby trap the Trx in the oxidized state 
and hence render it impossible to be reduced (compare E’0,Trx = -0.23 to -0.27 V; E’0,GSH = -0.25 V). 
We therefore hypothesize that the redox potential of the N-terminal domain should be in a 
similar range. With this we propose, that a reducing agent for FGE in vivo should display two 
cysteines in close vicinity to each other. 
   
Fig. 6-8: Left: Rate of product formation in dependency of increasing amounts of PepN (solid squares) and 
PepN*(empty circles). Both reducing peptides efficiently reduce FGE in the low micromolar range. Middle: Rate of 
product formation in dependency of the concentration of DTT. Right: Kinetic isotope effect of FGE4C in the presence of 
PepN and PepN*. None of the reducing peptides changes the rate limiting step of the FGE catalyzed reaction. 
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In case of two individual thiolates (see Scheme 6-2, B), after the initial attack of the first  
thiol one requires the presence of a second molecule. If this binding to the active site is slow (due 
to steric hindrance in the packed enzyme or colombic repulsion as described above) the back 
reaction can occur, which then releases the oxidized enzyme and the reduced thiol again. 
Additionally, the combination of two individual molecules to one oxidized homodimer disfavours 
the reaction entropically.    
We then went on to test the observed reducing capability with FGEhuman. While its N-terminal tag 
was shown to be without function in vitro earlier, these studies included additional DTT in the 
reaction mixture.[45][49] To test for possible effects, we used a full length version of human FGE 
with the N-terminal domain (residues 36-72) still in place (FGEhuman-FL). Although the overall 
reaction rates of (truncated) FGEhuman and FGEhuman-FL appear to differ significantly (inactivation of 
the protein samples, upon long time storage at Tstore = 4 °C, see Appendix Fig. 6-10), one can 
observe an overall trend. Along with FGEWT, the truncated FGEhuman does not react with GSH, 
whereas the reaction rate of FGEhuman-FL with GSH is less reduced (see Tab. 6-3). While this 
assessment is far from being complete, it should point out that the presence of the N-terminal 
domain of FGE as a covalently linked reducing agent can increase product formation and hint at a 
potential role of this domain also in vivo. The reader is thereby invited to follow the discussion in 
future publications.  
While working with human proteins tend to be difficult not only in terms of production and 
purification but also with regards to stability, bacterial homologues are often used to circumvent 
these issues. Synthesis of a fusion of a bacterial FGE (possibly FGEWT or FGE4C) with the human 
N-terminal domain could lead to data further supporting the peptide supplementation assay.  
 
Tab. 6-3: Relative activity of FGEs in the presence of GSH with respect to the rate of product formation in the presence 
of DTT. 
Variant kGSH/kDTT [%] 
FGEWT 12 
FGEhuman 16 
FGEhuman-FL 43 
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6.2 Conclusion 
This chapter shows the dependency of FGE on reducing agents. In the absence of a suitable 
reducing agent the enzyme is inactivated to a (most likely) sulfenic acid derivative of the active 
site cysteines. Which under particitpation of a reducing agent is reduced to the thiol. The scope 
of reducing agents has been expanded towards a more general view. While cysteine and cysteine 
derivatives, as well as glutathione do not efficiently reduce the enzyme, dithiol containing 
molecules readily reactivate FGE. The very small cysteamine reacts similarly fast, most likely due 
to the possibility to quickly diffuse in the packed active site. The requirement of two thiols being 
present in close vicinity to each other rather than a having a particular size was additionally 
demonstrated by usage of large peptides containing the thioredoxin like CxC motif. The peptide 
synthesis was inspired by the N-terminal domain of human FGE which is required for its in vivo-
reactivity. This domain has previously been reported to aid in localization in the ER where FGE 
activity is required. The presented data however suggests an additional role of this domain 
during catalysis (see Scheme 6-3). An in vitro reaction complemented with a peptide derivative of 
the N-terminal domain, showed fast catalysis with good affinities for the large reducing agent. 
While the active site could be too packed to be reduced by a thioredoxin/thioredoxin reductase 
system directly, intermediate reduction by the N-terminal domain might, facilitate this process. 
  
We and others have proposed the formation of a sulfenic acid during turnover. Along with 
copper being present throughout turnover, metal assisted reduction of the sulfenic acid is 
likewise possible. The oxidation equivalent will thereby be transfered to the metal centre from 
which the reducing N-terminal is oxidized to the sulfenic acid. Disulfide bond formation and 
release of water is then followed by reduction by a Trx-system to regenerate the active FGE 
catalyst.  
We do envision that these findings will drive the mechanistic investigations on FGE and that 
future investigations will identify similar reducing agents in FGEs from other organisms.  
 
Scheme 6-3: Hypothetical mechanism of the reduction of FGE by the N-terminal domain encoding the CxC motif. The 
ideal positioning of the two cysteines favors reduction of the active site cysteines. The exposed location of the oxidized 
N-terminal cysteines then allows for reduction by a suitable thioredoxin system. 
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6.3 Experimental 
Protein Expression and Purification. FGE mutants were produced as described previously (see 
chapter 4.3). Genes were transfered into BL-21 pLys E. coli cells. Precultures were inocculated 
with a single colony and incubated at Tinc = 37 °C overnight. Expression cultures of 1 L LB medium 
supplemented with kanamycine and chloramphenicol (50 mg/L and 34 mg/L, respectively) were 
inocculated with 1 mL of preculture. At OD = 0.6 – 0.8 cultures were induced by addition of IPTG. 
After additional 3 hrs of incubation at Texpress = 37 °C the cells were harvested by centrifugation. 
The protein was then isolated by Ni2+- affinity chromatography and dialysed into Tris buffer pH 8 
before storage at Tstore = -80 °C.  
Samples of FGEhuman and FGEhuman-FL were kindly supplied by Prof. Dr. Thomas Dierks, University of 
Bielefeld. 
Analysis of product formation in absence of reducing agent. If not stated otherwise, FGE was 
diluted to a final concentration of cFGE = 2 µM in a reaction buffer containing 200 µM substrate 
peptide, 50 mM EDTA, 50 mM NaCl and 50 mM Tris-HCl buffer pH 8. Samples containing 
additional copper salts were supplemented with CuSO4 at a final concentration of cmetal = 2 µM. 
Control reactions with DTT were additionally supplemented with the reducing agent at a final 
concentration of cDTT = 2 mM. The reaction was incubated at Treact = 25 °C. Throughout the 
reaction time, samples were quenched by addition of one volume equivalent of 4 M urea in 2 % 
TFA, which were subsequently analyzed by RP-HPLC (Gemini-NX, 5um C18 250 x 4.6 mm column, 
gradient see Tab. 6-4, RTsubstrate = 10.8 min, RTproduct = 13.1 min). Substrate concentration was 
determined by comparison to a calibration curve established with free 2-amino benzoic acid. 
Product concentration was determined by comparison to a calibration curve established with 
samples of fixed product concentration (known substrate concentration after complete 
turnover).  
Tab. 6-4: HPLC gradient used for the seperation of the substrate peptide and the product peptide of the FGE catalyzed 
reaction. Buffer A: H2O, 1 % MeCN, 0.1 % TFA. Buffer B: MeCN, 0.085 % TFA. Flow rate 1 mL/min. 
Time [min] Buffer B [%] 
0 15 
0.5 15 
12.0 20 
17.0 95 
20.7 95 
22.0 15 
25.0 Stop 
 
Analysis of structure after single turnover. To quantitatively produce FGE in the inacitve state 
FGE was diluted to a final concentration of cFGE = 90 µM in a reaction buffer containing 140 µM 
substrate peptide, 50 mM EDTA, 50 mM NaCl and 50 mM Tris-HCl buffer pH 8. After incubation 
overnight the samples were analyzed by SEC and HRMS. 
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Size exclusion chromatography. Size exclusion chromatography was performed on an Äkta Prime 
with a HiLoad Superdex 26/600 column at a flow rate of 1.5 – 2 mL/min in a 50 mM Tris buffer 
pH 8 supplemented with 200 mM NaCl.  
Analysis of reaction rates in the presence of different reducing agents. Reaction rates were 
determined using a discontinous HPLC assay as described previously (see chapter 4.3). Shortly, 
FGE was diluted to a final concentration of cFGE = 2 µM in a reaction buffer containing 200 µM 
substrate peptide, 2 mM reducing agent, 2 µM CuSO4, 50 mM EDTA, 50 mM NaCl and 50 mM 
Tris-HCl buffer pH 8. Throughout the reaction time, samples were quenched by addition of one 
volume equivalent of 4 M urea in 2 % TFA, which were subsequently analyzed by RP-HPLC.  
Peptide synthesis. Peptide substrate were synthesized by Fmoc solid phase peptide synthesis 
following standard protocols using a peptide synthesizer. Shortly, the most C-terminal amino acid 
was coupled to Rink amide resin. Deprotection of the primary amine is then accomplished by 
incubation with 40 % piperidine in DMF. The subsequent amino acid is added and activated by 
HCTU in DMF upon which coupling occurs. Unreacted peptide is quenched by addition of acetic 
anhydride in DMF. The peptide is sequentially synthesized with the last step being coupling of 2-
amino benzoic acid. Cleavage from the resin and deprotection of the amino acid side chains is 
simultaneously achieved by incubation with the cleavage cocktail (TFA:TIPS:DCM  96.5 : 2.5 : 1) 
for 3 hrs. Impurities have been removed by RP-HPLC after which lyophilization yields the final 
peptide substrate. The identity of the peptide was confirmed by ESI-MS.  
 
Tab. 6-5: Sequences and molecular weights of reducing peptides described in this chapter. 
ID Sequence MWcalc [Da] [M+H]
+
obs [Da] 
PepN Abz-AGSCGCGTPQRPGAHGSS-NH2 1746.7 1747.0 
PepN* Abz-AGSCGCGTRQPHGAPGSS-NH2 1746.7 1747.0 
 
 
Analysis of reaction rates in the presence of PepN and PepN*. Reaction rates were determined 
using a discontinous HPLC assay as described previously (see chapter 4.3). Shortly, FGE was 
diluted to a final concentration of cFGE = 2 µM in a reaction buffer containing 200 µM substrate 
peptide, 0 - 500 µM of either PepN or PepN*, 2 mM GSH, 2 µM CuSO4, 50 mM EDTA, 50 mM NaCl 
and 50 mM Tris-HCl buffer pH 8. Throughout the reaction time, samples were quenched by 
addition of one volume equivalent of 4 M urea in 2 % TFA, which were subsequently analyzed by 
RP-HPLC (RTsubstrate = 18.4 min, RTproduct = 19.8 min, RTPepN = 13.1 min, RTPepN* = 13.3 min). 
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Tab. 6-6: HPLC gradient used for the seperation of the substrate peptide and the product peptide of the FGE catalyzed 
reaction in the presence of PepN or PepN*. Buffer A: H2O, 1 % MeCN, 0.1 % TFA. Buffer B: MeCN, 0.085 % TFA. Flow 
rate 1 mL/min. 
Time [min] Buffer B [%] 
0 5 
0.5 5 
20.0 25 
22.0 95 
27.0 95 
28.0 5 
31.0 Stop 
 
Kinetic isotope effects. Reaction rates were determined using a discontinous HPLC assay as 
described previously (see chapter 4.3). Shortly, FGE was diluted to a final concentration of 
cFGE = 2 µM in a reaction buffer containing 200 µM substrate peptide, 0 - 400 µM of either PepN 
or PepN*, 2 mM GSH, 2 µM CuSO4, 50 mM EDTA, 50 mM NaCl and 50 mM Tris-HCl buffer pH 8. 
Throughout the reaction time, samples were quenched by addition of one volume equivalent of 
4 M urea in 2 % TFA, which were subsequently analyzed by RP-HPLC. The deuterated substrate 
was kindly provided by Pacal Engi and synthesized as described before (see chapter 4.3). 
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6.4 Appendix 
 
  
Fig. 6-9: Product formation in absence of reducing agent (open square) and after isolation of the inactivated FGE 
without additional reducing agent (solid square) and with added DTT (open triangle). The product formation is given as 
equivalents compared to the enzyme concentration. Left: Full scale and Right: zoom. 
 
 
 
Fig. 6-10: Rates of product formation of full length FGE from H. sapiens (FGEhuman-FL) in comparison to the truncated 
form (FGEhuman) and FGE from T. curvata (FGEWT). Rates were determined using DTT or GSH as a reducing agent. Low 
activity of FGEhuman is most likely an expression of the prolonged storage time of this very sample at Tstore = 4 °C which 
led to decomposition and thereby lost activity.  
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7. Optimization of FGE driven aldehyde formation in vitro 
 large number of investigations were carried out aiming to utilize the unique aldehyde 
residue for biotechnological applications.[10][81][120] The process mainly relies on the formation 
of an aldehyde functional group on the protein of interest and the following labeling reaction by 
chemical means. The CxPxR recognition motif can be introduced at either the C- or N-terminus or 
even within solvent accessible, flexible loop regions of the target protein.[83][80] Current protocols 
however display one major disadvantage, which is the low reactivity of the applied FGEs. Some 
setups require elevated temperatures that might conflict with the stability of the target protein, 
i.e. 30 °C.[84] Other reactions were performed at lower temperatures (i.e. 4 °C), but consequently 
demand longer incubation times of up to 48 hrs.[85] When copper was identified as an electron 
donor in the FGE catalyzed reaction, culture media were supplemented with the metal salts. The 
expressed FGE was thereby efficiently supplied with copper ions which was shown to successfully 
enhacne the aldehyde formation on antibodies in vivo.[97] In vitro reactions were similarly 
enhanced and reactions were then performed at 18 °C for 16 hrs with a 10 mol% catalyst 
loading.[94] We likewise developed protocols that enabled us to reach full conversion on a protein 
target within less than one hour with only 1 % of catalyst loading.[64]  
The utility of FGE for biochemical and biotechnological research has expanded to a wide array of 
applications, such as labeling reactions, the generation of protein-DNA conjugates  and protein 
(or even virus) surface immobilization.[121][122][123] For a successful implementation as a 
biotechnological tool, however, one requires high turnover rates and high catalytic efficiencies. 
The threshold for such applications appears to be kcat/KM > 10
3 M-1s-1 (see also Fig. 7-1). While 
others have reported efficiencies of kcat/KM,human ~ 10
4 M-1s-1 [94] for the human FGE variant, FGEWT 
from T. curvata fails to meet these requirements. We envision that the use of a bacterial protein 
that can simply be expressed in E.coli cells and shows resistance to high temperatures could be 
advantageous with regards to applicability in the laboratory. The incorporation of copper into the 
reaction mixture increased the activity of FGEWT to some extent (see also section 3.1). In pursuit 
of the mechanistic details of the FGE catalyzed reaction we generated an FGE variant with only 
two cysteine residues being present in the active site of FGE from T. curvata (FGE4C, see also 
section 3.1). The resulting catalyst happens to be almost 7-fold more active than the parent 
protein (kcat/KM, WT = 50 M
-1s-1; kcat/KM, 4C = 330 M
-1s-1).  We now show the identification of the 
residue responsible for the increased activity in FGE4C. Furthermore, we insert a Tyr->Phe 
mutation in close vicinity to the active site cysteines that additionally facilitates the reaction by  
 
 
Fig. 7-1: Catalytic efficiencies in M-1s-1 of different enzymes used in biotechnological applications (see also Tab. 7-1). 
A
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6 fold. The rate enhancing effects found in FGE4C and FGEY273F are then combined in a highly 
active variant with a catalytic efficiency of kcat/KM,4C-Y273F = 1.9 ∙ 10
3 M-1s-1. With this we envision 
that this easy-to-obtain, thermally stable and fast FGE variant will be of great advantage when 
aming to introduce aldehyde funtionalities on protein targets.    
   
 
Tab. 7-1: Catalytic efficiencies of selected enzymes used in biotechnological applications in copmarison to FGEWT. 
Protein Use kcat/KM [M
-1
s
-1
] 
TEV protease Protein hydrolysis 6.9 ∙103 [124] 
T4 DNA ligase DNA ligation (3.1 - 4.7) ∙107 [125] 
Trypsine Protein hydrolysis 1.9 ∙106 [126] 
Penicillin amidase Antibiotic semi-synthesis 4.2 ∙104 [127] 
Lipase Industrial Synthesis 2.4 ∙105 [128] 
Cellulase Paper industry 1.5 ∙106 [129] 
Sortase Bioconjugation 200 [130] 
Biotin ligase Biotinylation 1.2 ∙104  [131] 
FGEWT Bioconjugation 50 
[64] - 3.0 ∙104 [94] 
FGE4C-Y273F  1.9 ∙ 10
3 
 
 
 
7.1 Identification of in vitro gain of function cysteine mutation  
Gain of function mutations are found rarely during in vitro studies. However, the observation that 
the activity of FGE4C is enhanced demonstrates a key difference between in vivo and in vitro 
applications.  While nature has evolved the amino acid sequence of each enzyme over millions of 
years, outside of the cellular context the function of a residue might be significantly different. 
After our initial observation of the rate accaleration in FGE4C we then sought out to define the 
cysteine residue that is responsible for the increased activity.   
Wild type FGE contains a total of six cysteine residues, two of which are located in the active site 
and are required for turnover to occur.[48] The remaining four cysteines are found in the protein 
scaffold (see Fig. 7-2). It is noteworthy that, these cysteines scatter throughout the protein 
structure and are positioned in distances that do not allow for disulfide bond formation 
(dS-S > 8 Å, estimation based on a homology model of FGEWT based on a published crystal 
structure from human FGE, PDB 1Y1E). The residue with the highest degree of conservation is 
Cys298, which can be found in 83 % of the 500 closest homologs of FGEWT (after BLAST search). 
Two additional cysteine residues show high degrees of conservation with 68 % and 67 % for 
Cys187 and  Cys231, respectively. The residue with the lowest degree of conservation is Cys284, 
which can be found in only 0.6 % of the analyzed sequences. To adress the question of which  
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Fig. 7-2: Homology model of FGEWT based on a published crystal structure of human FGE (PDB 1Y1E). Cysteine residues 
are highlighed in green, with the active site cysteines assigned with a. Shown is the cartoon representation (top) and 
the surface representation (bottom) to indicate solvent exposure. 
mutation causes the increased activity, we designed four variants of the activated FGE4C variant. 
In each of these mutants one cysteine residue was mutated back to its original position (see Tab. 
7-2), yielding four proteins with three cysteine residues each. Most of the new variants showed 
reaction rates comparible to that of FGE4C. Only FGECASA, with Cys187 back in place, displayed a 
reduced activity to the level of FGEWT indicating that this residue causes the change in activity. 
The alanine residue replacing Cys187 is found at this position in 27 % of the close homologues of 
FGEWT, indicating that replacement of cysteine by alanine has similarly occured in many 
organisms during evolution and should therefore be a tolerated mutation. We consequently 
adressed this question with an additional control by generating a mutant with only cysteine at 
position 187 being replaced to alanine. In agreement with the previous observation this mutant 
shows elevated rates of product formation similar to FGE4C. Cysteine 187 is located in a 
hydrophobic pocket in the close vicinity to the active site (see Fig. 7-3). To assay the solvent 
 
Tab. 7-2: FGE variants with different cysteine patterns to identify the cysteine residue that causes the increased activity 
of FGE from T. curvata. Shown are the residues at the various positions as well as the corresponding reactivity and 
midpoints of thermal transition. 
Protein 
Position 
kobs [min
-1
] Tm [°C] 
187 231 284 298 
FGEWT C C C C 0.3 68 
FGE4C A A S A 0.7 63 
FGECASA C A S A 0.3 65 
FGEACSA A C S A 1.0 62 
FGEAACA A A C A 1.6 57 
FGEAASC A A S C 1.0 61 
FGEACCC A C C C 0.9 63 
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Fig. 7-3: Left: Cysteine 187 (green) with the surrounding loop region (cyan) and conserved hydrophobic residues shown 
as sticks (residues within 5 Å distance of the cysteine sulfur atom). Right: Sequence logo showing the conservation of 
the hydrophobic residues (black). The degree of conservation for each residue was determined to be: Y173: 63 %; 
W175: 100 %; L179: 98 %; I189: 94 %; D202: 87 %: F213: 67 %; N222: 91 %; A224: 24 %.  
accessibility of this residue we incubated FGE with 2-iodoacetamide (IAA). While other cysteines 
can efficiently be alkylated using IAA, Cys187 does not form covalent adducts (see Appendix Fig. 
7-9), indicating that the surrounding loop structure is stable and forms a tight pocket preventing 
nucleophilic attack of IAA. Many residues in this hydrophobic area surrounding Cys187 are highly 
conserved and point towards the cysteine residue (60 - 100 % in in the 500 closest homologues 
after BLAST search, except for Ala224) indicating the importance of the hydrophobicity of this 
pocket (see Fig. 7-3).   
Introduction of mutations into a protein sequence can perturb the structure or fold of a protein. 
We therefore performed circular dichroism spectroscopy to analyze changes in secondary 
structure and compare the mutants resistance to increasing temperatures (see Tab. 7-2 and 
Appendix Fig. 7-10). The effect of the presence of copper on the thermal resistance has been 
discussed before (see section 4.1.3). Due to the increased denaturing temperature we were not 
able to precisely determine the midpoint of transition since the second state is not reached until 
the maximal temperature of Tmax = 90 °C. We therefore only evaluated the temperature 
dependend CD signal in absence of copper(I). The secondary structure of the different variants 
does not differ significantly. With regards to thermal stress, however, Cys187 appears to have a 
slight effect. While mutants containing a cysteine residue at position 187 unfold at higher 
temperature (Tmelt ≥ 65 °C), enzymes with an alanine residue at this position show lower 
tolerance for thermal stress (Tmelt ≤ 63 °C). The difference might be minor, but the observation 
shows, that perturbation of the carefully crafted loop environment decreases the protein 
stability. .  
 
 
Fig. 7-4: Reaction rate of FGEaccc at increasing substrate concentration. vmax = 3.9 min
-1; KM = 280 μM. 
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The effect of the cysteine to alanine mutation in FGEaccc is mostly based on an increased kcat value 
of kcat,ACCC = 3.9 min
-1 in comparison to FGEWT (kcat,WT = 1.6 min
-1; see Fig. 7-4 and chapter 4). The 
KM-value is similarly decreased as for FGE4C with half the KM value of FGEWT (KM,WT = 580 µM; 
KM,4C = 200 µM; KM,ACCC = 280 µM). In summary these effects add up to a catalytic efficiency 
comparible to that of FGE4C, which is six to seven fold higher than that of the parent protein 
(kcat/KM,WT = 50 M
-1s-1; kcat/KM,4C = 330 M
-1s-1; kcat/KM,ACCC = 230 M
-1s-1). In summary the variant with 
only Cys187 mutated to alanine (FGEACCC) shares the kinetic properties of FGE4C as well as the 
reduced thermal stability, suggesting that this mutaion is indeed responsible for the enhanced in 
vitro reactivity of FGE4C. 
Conclusive rational, however, still lacks. While Cys187 is found in 92 % of the 500 closest 
prokaryotic homologues of FGE, it is not found in a single one of the 500 closest eukaryotic FGE-
like proteins. This shows that Cys187 is exclusive to bacteria and archaea, suggesting that it was 
introduced after these classes of organisms have evolutionary diverged.  
7.2 Mutation of active site Tyr273 
In pursuit of a more active catalyst for possible in vitro applications, we additionally mutated 
other residues in close vicinity to the active site cysteine residues (see Fig. 7-5). Serine at position 
266, as well as the two more distant tryptophane side chains at position 108 and 109 were shown 
to be essential for turnover. Mutation of these residues led to lower catalytic efficiencies 
(kcat/KM,W108A,W109A = 0.03 M
-1s-1; kcat/KM,S266A = 0.82 M
-1s-1 vs. kcat/KM,WT = 50 M
-1s-1, see also section 
5.1). The two tryptophane residues are located in a distance of dCys-SH : Trp-NH ≥ 10 Å to the active 
site cysteines, whereas Ser266 is more closely positioned (dCys-SH : Ser-OH = 6.2 Å). The entry towards 
the active site cysteines is mainly dominated by the presence of the two tryptophane residues in 
Fig. 7-5 as well as a tyrosine functional group even closer to the cysteines (Tyr273, 
dCys-SH : Tyr-OH = 4.5 Å). This specific tyrosine is present in 99 % of the 500 closest homologues of 
FGE, additionally suggesting a role in catalysis. A side chain in such close vicinity most likely has 
an effect on the reactivity of the nearby cysteine. The role of this tyrosine residue (Tyr340 in 
human FGE) has been investigated before. The findings, however, are contrasting. Earlier 
publications describe the mutation Tyr340Phe to not affect the activity significantly, whereas 
recent investigations characterize this tyrosine residue as having an effect on FGEs activity.[48][94] 
However, further details are not given. We therefore investigated the role of this residue.  
  
   
Fig. 7-5: Left: Active site of FGEWT (homology model based on a published crystal structure of FGEhuman) with Ser266, 
Trp108 and Trp109 (red) as well as Tyr273 (green). Mutation of the serine or tryptophane residues yields a less active 
variant, whereas mutation of Tyr273 to Phe provides a more active catalyst during in vitro experiments. Right: 
Michaelis-Menten plot of FGEY273F, showing the rates of product formation at increasing substrate concentration. 
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Surprisingly, during our in vitro studies, the mutant FGE
(kcat/KM,Y273F = 340 M
-1s-1). Substrate binding appears not to be influe
Tyr273, since the KM does not significantly differ from that of FGE
KM,Y273F = 560 µM). In an X-ray structure of 
distinct orientations upon substrate bi
substrate shows a single orientation only.
prozess, during our in vitro studies the phenol group seems to be insignificant for substrate 
binding. To test whether the 
investigated the rate of product formation in the presence of the previously described 
deuterated substrate (see also section
and FGE4C the removal of the β
(KIEY273F = 2.8 ± 0.1, Appendix Fig. 
remains the same. Similarly the temperature of therma
wild type enzyme (Tunfold,Y273F = 68
We then went on to test, whether this mutation and the previously described cysteine mutations 
of FGE4C would interfere with each other
enhancements of each mutant would be additive in a
Tyr273Phe mutation and the four 
The newly produced enzyme shows a katalytic efficiency which lies
of FGEY273F and more than 5-fold over that of FGE
conclude that the rate enhancing effects 
FGE4C-Y273F. Overall, the resulting variant shows a 35
enzyme. The KM value, in particular, is similarly 
(KM,4C = 230 ± 40 µM, KM,4C-Y273F =
involved in substrate binding. Tyrosine residues perform key interactions in some copper(II) 
containing proteins such as galactose oxidase or amine oxidases (see also section 
that copper binding is not perturbed in FGE mutants lacking Tyr273, we determined the binding 
affinity of FGEY273 using the previously described method for copper affinity determinations (see 
also chapter 5). The KD of FGEY273F
which is in good agreement with the binding affinities of FGE
(KD,WT = 10
-17.1), hence we conclude that copper binding is not perturb
FGEY273F. 
 
  
Fig. 7-6: Left: Crystal structure of human FGE with bound substrate peptide showing different orientations of the 
Tyr340 (PDB 2AIJ).[56] Middle: Michaelis
increasing substrate concentrations. The more active variant shows an increased kcat value as well as a decreased KM 
value, in comparison to FGEWT.  Right:
(BCS). 
Y273F shows reactivity above that of FGE
nced by the
WT (KM,WT =
FGEhuman there is electron density for Tyr340 in 
nding (see Fig. 7-6, left), whereas the structure without 
[56] While this might be an artefact of the crystalization 
displacement of Tyr273 changes the rate limiting step, we 
 4.1). In good agreement with the obersations with FGE
-proton of the substrate cysteine by FGEY273F
7-12). We therefore conclude that the overall mechanism 
l unfolding is comparable to that of the 
 °C, see Appendix Fig. 7-10).   
. Of particular interest is whether 
n FGE4C-Y273F variant containing both, the 
cysteine mutations. We therefore created this very FGE variant. 
 more than 5
4C (kcat/KM,4C-Y273F = 1900 M
-1s-
of the mutations in FGE4C and FGEY273F
-fold higher efficiency tha
decreased as observed for FGE
 100 ± 30 µM), which again is indication that Tyr273 is not 
 was determined to be KD,Y273F = 10
-17.0 M (see 
WT and other FGE variants 
ed in the active site of 
 
-Menten plot of FGE4C-Y273F. The rate of product formation is assayed at 
 Copper binding of FGEY273F in competition with bathocuproinedisulfonic acid 
WT 
 presence of 
 580 ± 40 µM vs. 
two 
WT 
 is rate limiting 
the rate 
-fold above that 
1). We therefore 
 are added up in 
n the wild type 
4C 
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Copper(II) containing LPMOs such as glucoside hydrolases (GHs) likewise display a tyrosine 
residue in the coordination sphere of the metal ion. A very similar enzyme class, the “33 familiy 
carbohydrate binding models” (CBM33), catalyze copper dependent cleavage of chitin chains. 
While crystal structures of these enzymes show similar metal binding sites, the conserved and 
metal coordinating tyrosine residue in GHs is displaced by a phenylalanine in CBMs. The metal 
binding capability and hence reactivity however remains.[133] Although, the metal binding affinity 
in GHs are higher than in CBMs, in FGE, the mutation of tyrosine to phenylalanine does not affect 
the metal binding affinity.  
Small peptide substrates provides an ideal tool for mechanistic investigations and first 
explorational experiments for method development. However, different properties might 
influence the interactions with the target protein in vivo. Such factors are the concentration of 
available oxygen in vivo or the participation of a different reducing agent (see also chapter 6).  
Additionally, since FGE catalysis is believed to occur co- or post-translational with sulfatases, the 
substrates in vivo are much bigger proteins. A prolonged peptide sequence might interact 
differently with FGE than a short peptide. Larger substrates might interfere with FGE by steric 
hindrance or bending of the CxPxR recognition site, which could reduce FGEs capability to bind 
the substrate. We addressed these concerns by investigating the activity of FGE4C-Y273F with 
different protein substrates. The selected GFP substrates have the recognition motif installed at 
different locations (see Fig. 7-7). The FGE recognition site (ald-tag) was positioned either at the N-
terminus or in a loop region that has been described to tolerate modifications without loss of the 
characteristic fluorescence.[80][132] GFP with ald-tags in the loop was used with different lengths of 
sequences, since we anticipated that the loop formation adds constraints to the substrate. A 
longer sequence might lower this substrate bending and potentially allow for better recognition 
by FGE. We therefore incubated these different GFP samples with either FGEWT or FGE4C-Y273F and 
analyzed the substrate to product distribution by means of HRMS (see Fig. 7-8). To increase the 
mass difference between the thiol substrate and the aldehyde containing product we incubated 
the fGly containing product with O-(4-nitrobenzyl)hydroxylamine. While the FGE reaction is 
performed at pH 8, labeling is achieved at pH 4.5. This lower pH will simultaneously quench the 
FGE reaction (see chapter 4). Interestingly, loop1-GFP with the short insert is not accepted as a 
substrate and no product is observed after 90 mins of incubation with either FGEWT or FGE4C-Y273F. 
In contrast, the N-terminal tag as well as the longer sequence in the loop region (loop2-GFP) are 
readily converted. In agreement with the previous observations with the peptide 
 
 
Fig. 7-7: Structure of GFP (PDB 1GFL). Sites where FGE recognition sequences have been introduced are highlighted in 
red. Beta sheets surrounding the site of the internal loop are highlighted in green. Sequences that were introduced are 
given with their respective location (a or b).  
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Scheme 7-1: Labeling of GFP with hydroxylamine after FGE catalyzed oxidation.  
 
substrate, FGE4C-Y273F performs faster catalysis on both substrate peptides. Catalysis of FGEWT on 
the N-terminal tag is incomplete after 90 min. The percentage of product is 38 %. The internal 
cystein in the loop-tag seems to be less accessible since only 24 % of product can be identified 
after 90 min of incubation. The more constrained structure of the recognition motif in the loop 
region seems to conflict with efficient catalysis. FGE4C-Y273F however, performs efficient catalysis 
on both substrates. In crystal structures of FGEhuman with co-crystallized substrate the 
corresponding Tyr340 adopts two distinct orientations. A second structure, co-crystallized with a 
longer substrate, shows the tyrosine only in the orientation facing towards the substrate.[56] 
Removal of the hydroxyl group from this tyrosine residue might therefore favour the orientation 
with the phenylalanine facing away from the substrate. The phenylalanine would then open up 
 
 
Fig. 7-8: Conversion of ald-tag containing GFP with the recognition motif installed at either the N-terminus (top) or in a 
loop (bottom) with FGEWT (A & C) and FGE4C-Y273F (B & D). The substrate is indicated by the asterisk whereas the product 
peak is highlighed by the open circle. MWcalc,ald-GFP = 29253.1 Da, MWobs = 29249.6 Da. MWcalc,loop2-GFP = 30280 Da, 
MWobs = 30258.5 Da. ΔMWmodif,calc = 132.1 Da, ΔMWmodif,obs = 130.5 – 132.1 Da. The additional product peak in loop2-
GFP samples represents glycosylation on the His6-tag (ΔMWGlyco = 178 Da). 
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the substrate channel allowing for the substrate to enter the active site even in a constrained 
sequence. Not only is the rate of N-terminal oxidation with FGE4C-Y273F significantly faster but 
also is the bend substrate oxidized similarly fast. In both cases the reaction mixture is absent of 
substrate after 90 min and contains only the labeled product.  
We therefore conclude, that the most active FGE variant described here shows an elevated 
reaction rate as well as a higher tolerance to substrate constraints. While the wild type protein 
does catalyze oxidation of the protein substrates, catalysis is significantly more efficient when 
using FGE4C-Y273F. We do envision that this variant will be valuable especially when modification 
are to be introduced in sterically demanding protein regions. 
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7.3 Conclusion 
This chapter shows the development of a set of FGE variants with increased activity. We 
identified the mutation causing the increased activity in FGE4C to be Cys187Ala. A variant with 
only Cys187 replaced by alanine shows comparable reaction rates as FGE4C and shows similar 
resistance to increased temperatures.   
An additional mutation in very close proximity to the active site (d = 4 – 5 Å) has beneficial effects 
on the reaction rate. The mutant FGEY273F is seven fold more active than the parent protein but 
shows similar copper binding affinities and is similarly stable as the wild type. Importantly the 
effects of the individual mutations are additive in a mutant containing the activating cysteine 
mutations as well as the Tyr273Phe mutation. The resulting mutant shows a catalytic efficiency 
38-fold higher than the wild type protein. With a catalytic efficiency of kcat/KM = 1900 M
-1s-1 
FGE4C-Y273F suffices to serve as a tool for biotechnological application. The applicability of this 
highly active variant was shown by reacting FGE4C-Y273F with different authentic target proteins. 
GFP with the FGE recognition motif installed at either the N-terminus or in a solvent accessible 
loop was effectively converted within 90 min at a target to catalyst ratio of 380 : 1.   
With the high degree of resistance to heat, we therefore believe, that this mutant will prove to 
be very valuable for the incorporation of aldehyde functionalities into recombinant proteins. 
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7.4 Experimental 
Plasmid Construction. Mutations were introduced by site directed mutagenesis using the vector 
pET28-FGEWT or pET28-FGE4C as a template. Synthetic primers were ordered from Mycrosynth 
and are shown in Tab. 7-3. After PCR, the fragments as well as the pET28 target vector were 
treated with NdeI and XhoI restriction enzymes, followed by ligation of the gene into the target 
vector by T4 DNA ligase. The identity of final plasmids was confirmed by sequencing analysis 
(Microsynth). 
Plasmids and protein samples of ald-GFP, Loop1-GFP and Loop2-GFP were kindly supplied by Dr. 
Roxana Lemnaru, Universtity of Basel. 
 
Tab. 7-3: Primer sequences used for the mutation of the FGE variants described in this chapter. 
FGE variant 
Primer 3’  5’ 
Sense Antisense 
FGEWT ATATCATATGCCCTCGTTCGACTTCG ATATCTCGAGCTACAGCGGGTC 
FGE4C ATATCATATGCCGTCGTTTGACTTTG ATATCTCGAGTTACAGCGGATC 
FGECASA GCCATCGTTGCAATATTTGGCAAGGTA GCCAAATATTGCAACGATGGCGGCCAC 
FGEACSA GGGAATGGTGCGCCGATTGGTGGTCAG AATCGGCGCACCATTCCCACACATTGC 
FGEAACA TCGTACGTGCAATACGCCGGACTCAAG GCGTATTGCACGTACGAGCTGCAACAC 
FGEAASC 
ATATCTCGAGTTACAGCGGATCGGCGGCGCAGC
GAAAACCCGT 
- 
FGEACCC ATATGGCACCGCGCAAACATCTGGCAG ATATAGATGTTTGCGCGGTGCCGGCC 
FGEY273F ACGAGTCGTTCTGCAACCG CGGTTGCAGAACGACTCGT 
FGE4C-Y273F CACGAATCCTTTTGTAATCGCT AGCGATTACAAAAGGATTCGTG 
 
 
Protein Expression and Purification. FGE mutants were produced as described previously (see 
chapter 4.3). Genes were transfered into BL-21 pLys E. coli cells. Precultures were inocculated 
with a single colony and incubated at Tinc = 37 °C overnight. Expression cultures of 1 L LB medium 
supplemented with kanamycine and chloramphenicol (50 mg/L and 34 mg/L, respectively) were 
inocculated with 1 mL of preculture. At OD = 0.6 – 0.8 cultures were induced by addition of IPTG. 
After additional 3 hrs of incubation at Texpress = 20 - 37 °C the cells were harvested by 
centrifugation. The protein was then isolated by Ni2+- affinity chromatography and dialysed into 
Tris buffer pH 8 before storage at Tstore = -80 °C.  
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Tab. 7-4: Calculated and observed molecular weights of proteins described in chapter 6 with comments on the mass 
difference. 
Protein MWcalc [Da] MWobs [Da] Comment 
FGECASA 35227.9 35224.2 Disulfide bond 
FGEACSA 35227.9 35224.8 Disulfide bond 
FGEAACA 35211.9 35182.6 Undesired mutation Y277H 
FGEAASC 35227.9 35225.0 Disulfide bond 
FGEACCC 35276.0 35272.5 Disulfide bond 
FGEY273F 35292.1 35291.0 - 
FGE4C-Y273F 35179.9 35179.1 - 
 
Labeling with 2-iodo acetamide. FGE was diluted to a final concentration of cFGE = 45 µM in a 
reaction mixture containing 2 mM DTT, 50 mM EDTA, 50 mM NaCl and 50 mM Tris-HCl pH 8. The 
reaction was incubated at RT for 30 min, after which 2-iodo acetamide was added to a final 
concentration of cIAA = 5 mM. The reaction was then incubated at RT for 120 min. Protein 
modification was subsequently analyzed by LC/HRMS. 
 
Analysis of reaction rates. Reaction rates were determined using a discontinous HPLC assay as 
described previously (see chapter 4.3). Shortly, FGE was diluted to a final concentration of 
cFGE = 2 µM in a reaction buffer containing 200 µM substrate peptide, 2 mM DTT, 2 µM CuSO4, 
50 mM EDTA, 50 mM NaCl and 50 mM Tris-HCl buffer pH 8. Throughout the reaction time, 
samples were quenched by addition of one volume equivalent of 4 M urea in 2 % TFA, which 
were subsequently analyzed by RP-HPLC.  
The deuterated substrate was kindly provided by Pascal Engi and synthesized as described before 
(see section 4.3). 
 
Michaelis Menten Kinetics. Reaction rates at increasing amounts of substrate were determined 
using a discontinous HPLC assay. FGE was diluted to a final concentration of cFGE = 2 µM in a 
reaction buffer containing 0 - 1000 µM substrate peptide, 2 µM CuSO4, 5 mM DTT, 50 mM EDTA, 
50 mM NaCl and 50 mM Tris-HCl buffer pH 8. The reaction was incubated at Treact = 25 °C. 
Throughout the reaction time, samples were quenched by addition of one volume equivalent of 
4 M urea in 2 % TFA, which were subsequently analyzed by RP-HPLC (see above). 
CD measurements. Circular dichroism measurements have been performed on a Applied 
Photophysics ChiraScan at TCD = 20 °C. Mean residue elipticity was determined in a 50 mM Tris 
Buffer pH 8 containing 50 mM NaCl and 2 mM DTT at a final protein concentration of 
cFGE = 10 μM. 
 
Determination of thermal unfolding by circular dichroism. FGE was diluted to a final 
concentration of cFGE = 10 µM in a buffer containing 50 mM Tris, 50 mM NaCl and 2 mM DTT. 
Thermal unfolding was monitored at λCD = 222 nm in a quartz cuvette of 1 mm pathlength while 
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heating at 1 °C/min in steps of 1 °C. Data points were fitted with a boltzman distribution curve 
(see chapter 4.3). 
 
Copper(I) affinity determination. Copper affinities were assayed as described above (see also 
chapter 5.3) Shortly, protein samples were diluted in a 50 mM Tris buffer pH 8 containing 20 µM 
CuSO4, 200 µM bathocuproine disulfonic acid (BCS), 2 mM cysteamine and 4 mM Na2S2O4. The 
reaction mixture was vortexed and the absorbance at λBCS = 483 nm was determined on a Cary 
300 Bio UV/vis spectrophotometer. The concentration of free Cu : BCS2 was calculated using the 
molar extinction coefficient of BCS εBCS = 13000 M
-1cm-1. The equilibrium is described by Eq. 4 
(see chapter 5.3 and Ref. [100]). Upon linearization the metal affinity is determined. 
Conversion of protein substrate. To assay the reactivity of FGE in presence of an authentic 
protein substrate we incubated 0.2 µM of FGE with 75 µM of substrate in a Tris buffer pH 8 
containing 2 mM DTT, 50 mM EDTA, 50 mM NaCl at Tinc = 25 °C. After various time points the 
reaction was quenched by addition of one volume equivalent of 10 mM 
4-nitro-benzylhydroxylamine in a 100 mM acetic acid buffer pH 4.5 supplemented with 6 M urea 
to ensure complete accessibility of the fGly side chain and inactivation of FGE. The labeling 
reaction was incubated for 1 – 2 hrs at RT prior to acidification by addition of formic acid and 
analysis of the protein mass by LC/HRMS. 
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7.5 Appendix 
  
Fig. 7-9: Different FGE variants after covalent labeling with 2-iodo acetamide (IAA, ΔMW = 57 Da). Spectra without 
addidion of alkylating agent are shown above, whereas IAA-labeled samples are shown below.Left: FGEWT is labeled 
with 2 – 3 IAA units. MWcalc,WT = 35309.1 Da; a: MWobs = 35307.1 Da, b: MWobs = 35421.4 Da, c: MWobs = 35477.6 Da, d: 
MWobs = 35484.8 Da, e: MWobs = 35599.6 Da, f: MWobs = 35655.8 Da. Middle:FGE4C is labeled with 2 IAA units. 
MWcalc,4C = 35195.9 Da; a: MWobs = 35194.7 Da, b: MWobs = 35308.7 Da, c: MWobs = 35372.9 Da, d: MWobs = 35486.9 Da. 
Right: FGEcasa is labeled with 2 IAA units. MWcalc,casa = 35227.9 Da; a: MWobs = 35227.0 Da, b: MWobs = 35340.2 Da, c: 
MWobs = 35405.0 Da, d: MWobs = 35518.8 Da. Mass increments of ΔMW = 178 Da result from glycosylation of the N-
terminal His6-tag.
[88]  
 
 
 
Fig. 7-10: Determination of mid-point of thermal transition of different FGE variants in the absence of copper salts. 
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Fig. 7-11: Michaelis-Menten plot of FGEY273F showing the reaction rate at increasing substrate concentration. The data 
was fitted with a hyperbolic curve (kobs=([S]∙kcat)/([S]+KM)) to obtain kcat/KM,Y273F = 21000 ± 7000 M
-1min-1. 
 
Fig. 7-12: Reaction rate of FGEY273F in the presence of deuterated substrate. The kinetic isotope effect when using a 
substrate with the β-proton being replaced by deuterium is KIEY273F = 2.8 ± 0.1 and hence comparable to that of FGEWT. 
Tab. 7-5: Amino acid sequences of GFPs with different tags as protein substrates for FGE conversion. The FGE 
recognition motif CxPxR is highlighted as bold letters, the inserted sequence is underlined.  
Protein ID Sequence 
Ald-GFP GTPLCGPSRAHMGSGASKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATY
GKLTLKFICTTGKLPVPWPTLVTTLCYGVQCFSRYPDHMKRHDFFKSAMPEGYVQ
ERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVY
IMADKQKNGIKVNFKTRHNIEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQS
ALSKDPNEKRDHMALLEFVTAAGITHGMDELYKLEHHHHHH 
Loop1-GFP GSSHHHHHHSSGLVPRGSHIHMGSGASKGEELFTGVVPILVELDGDVNGHKFSVS
GEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTLCYGVQCFSRYPDHMKRHDFFK
SAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKL
EYNYNSHNVYIMADKGTPLCGPSRNGIKVNFKTRHNIEDGSVQLADHYQQNTPI
GDGPVLLPDNHYLSTQSALSKDPNEKRDHMALLEFVTAAGITHGMDELY 
Loop2-GFP GSSHHHHHHSSGLVPRGSHIHMGSGASKGEELFTGVVPILVELDGDVNGHKFSVS
GEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTLCYGVQCFSRYPDHMKRHDFFK
SAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKL
EYNYNSHNVYIMADKAGKGTPLCGPSRAGNGIKVNFKTRHNIEDGSVQLADHYQ
QNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMALLEFVTAAGITHGMDELY 
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Fig. 7-13: SDS-PAGE picture of Different FGE variants. 
MWM; B: FGEACSA. Middle right: A: FGEWT
 
  
  
Left: A: MWM; B: FGECASA; C: FGEAACA; D: FGE
; B:FGE4C; C: FGECASA; D: FGEACCC. Right: A: MWM; B: FGEY273F
 
AASC. Middle left: A: 
; C: FGE4C-Y273F. 
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8. Final Conclusion and Outlook 
his thesis describes the identification of FGE as a copper-dependent oxidase. It was shown 
that FGE requires equimolar amounts of copper to reach its highest activity, whereas other 
transition metals were not accepted (see chapter 4). Copper binds to the reduced active site 
cysteines that were previously described as being crucial for turnover. The copper(I) ion remains 
in the active site for multiple turnovers, but can be replaced by silver which renders FGE inactive 
(see chapter 5). This observation further supports the role of copper as a redox cofactor. The 
binding of copper to FGE from Thermomonospora curvata is accompanied by a conformational 
change in the protein structure and a shift in resistance to high temperatures (up to T ~ 80 °C). 
This conformational change also occurs with Ag+ indicating that the structural adjustment and the 
increased activity in presence of copper are decoupled. It was moreover shown that the FGE : 
copper complex is further stabilized in the presence of the substrate, suggesting that the sulfur 
atom of the substrate cysteine is involved in the active complex (see also chapter 5). 
Furthermore, we propose that the reducing agent, involved in FGE reactivation in vivo, depends  
 
 
Scheme 8-1: Mechanistic proposal of fGly formation under participation of copper as a cofactor based on biochemical 
investigations performed in this thesis. 
T 
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on a CxC motif similar to thioredoxin-like reducing proteins (see chapter 6). This motif can be 
found in the previously described N-terminal domain of human FGE, suggesting a participation of 
this peptide chain in the reduction of FGE.  
In addition to these mechanistic findings, the utility of FGE from T. curvata for protein labeling 
applications was demonstrated (see chapter 7). We introduced several cysteine mutations 
outside the active site and a tyrosine mutation inside the active site. This new FGE4C-Y273F variant 
was shown to be highly active and was able to oxidize more than a 300-fold excess of target 
protein within 90 min at RT. It was shown that this variant is easy to produce, resists high 
temperatures and has 30-fold higher catalytic efficiency than the parent protein. We believe that 
this variant will be of great advantage in the development of new FGE-based labeling 
applications. 
Further experiments are needed to assay the role of the N-terminal domain during the reduction 
of FGE. Testing a fusion protein of FGEWT with PepN attached to the N-terminus should show 
whether FGE can potentially accept other reducing agents in vivo. Moreover, the presence of a 
sulfenic acid intermediate of FGE has not directly been shown. The development of new sulfenic 
acid labeling methods might allow for the detection of this proposed intermediate. If the release 
of the product and the subsequent reduction of FGE follow a ping-pong mechanism, a dimedone 
derivative could be localized in a substrate-like peptide. At reducing agent limiting conditions, the 
dimedone-containing peptide might bind to the active site after the product has been released 
and possibly be covalently linked to the sulfenic acid. 
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